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The intestinal microbiome is a dynamic ecosystem made up of bacteria, fungi, and protists, 
which together promote the overall health of the host. It regulates digestion and absorption of 
nutrients, prevents colonization of the intestinal tract by pathogenic organisms, drives the 
development of the host immune system, and even regulates chemical processes outside of the 
gastrointestinal tract, including the brain. Modulation of the intestinal microbiome can promote 
the growth and health of commercially important agriculture and aquaculture species in order to 
increase production and reduce costs. Probiotics, live beneficial bacteria incorporated in feed, 
and prebiotics, non-digestible feed ingredients, primarily inulin and oligosaccharides, are two of 
the primary modulation techniques used currently in aquaculture. Probiotics promote the 
colonization of the gut by the bacterial species of interest, while prebiotics promote the growth of 
beneficial bacteria by providing a substrate and feed source for the microbes. While there has 
been a lot of research on alternative feed ingredients to reduce cost and reliance on wild-caught 
fish in aquaculture feed, there are few studies on the effect of these feed ingredients on the 
intestinal microbiome. Many of these alternative ingredients are plant-based and thus provide a 
natural level of potential prebiotics that would modulate the intestinal microbiome of the 
aquaculture species. Tilapia (Oreochromis sp.) are the most widespread aquaculture species in 
the world due to their relative fecundity, omnivorous feeding habits, and tolerance of marginal 
growing conditions, making them ideal study species for alternative feed ingredients.  The goal 
of this dissertation is to investigate the modulation of the intestinal microbiome of hybrid tilapia 
(Oreochromis niloticus x O. mossambicus) using alternative feed ingredients as potential 
prebiotics. Next generation sequencing was utilized to determine how the microbiome changes 
with alternative carbohydrate, protein, and lipid sources. The results of this work suggest that 
moringa leaf (Moringa stenopetala), cassava (Manihot esculenta), and microalgae (Arthrospira 
platensis and Schizochytrium limacinum) can be included up to 12%, 26.2%, and 100%, 
respectively, without significantly slowing the growth parameters, making them acceptable feed 
alternatives. Additionally, the three alternative feed ingredients significantly altered the 
microbiome of hybrid tilapia.    
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CHAPTER 1 INTRODUCTION 1 
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 3 
Abstract 4 
Tilapia (Oreochromis sp.) are the most widespread aquaculture species grown and are 5 
expected to continue increasing to meet the growing demand for fish by an ever-increasing 6 
human population. Fish health management is one of the primary concerns in the production of 7 
aquaculture species and a number of studies have been conducted to determine new 8 
procedures for reducing disease of aquaculture fishes, such as tilapia. The use of antibiotics as 9 
a preventative method is common practice in most aquaculture facilities; however, consumer 10 
demand and increasing incidence of antibiotic resistance have caused the reduction in the use 11 
of antibiotics being administered regularly. A more recent strategy is the incorporation of 12 
antibiotic alternatives, such as probiotics, prebiotics, and alternative feed ingredients to promote 13 
growth and health of the fish through the modulation of gastrointestinal microbiota. Intestinal 14 
autochthonous microbiota fulfils a number of important roles in host digestion, immunity, and 15 
intestinal integrity. In the past, the majority of studies on the intestinal microbiota of tilapia used 16 
culture-based methods that are not representative of the entire community. With the 17 
advancement of molecular techniques, current studies are utilizing culture-independent methods 18 
to monitor the microbial modulation in the tilapia gastrointestinal tract. This review discusses the 19 
effects of antibiotics, probiotics, prebiotics, and alternative feed ingredients on the intestinal 20 
microbiota of tilapia using culture-independent techniques. Though strides have been made in 21 
the understanding of tilapia intestinal microbiota, more research is needed into the microbial 22 
ecology, alternative feedstuff effects, and economic impacts of modulating intestinal microbiota 23 
of tilapia. 24 
 25 
Introduction 26 
Gastrointestinal (GI) microbiota are essential to their host’s growth and survival (Burr, Gatlin, & 27 
Ricke, 2005; Cahill, 1990; Fouhy, Ross, Fitzgerald, Stanton, & Cotter, 2012; Sukanta K Nayak, 28 
2010; Nicholson et al., 2012). They aid in digestion and energy homeostasis, prevent 29 
colonization of infectious agents, and help maintain the mucosal immunity of their host (Cahill, 30 
1990; D. Merrifield & Ringø, 2014; S. K. Nayak, 2010; Nicholson et al., 2012). Increased 31 
research into the GI microbiota of mammalian vertebrates in the past decades has provided a 32 
clear picture of the benefits of GI microbiota and how microbial modulation can affect meat 33 
producing livestock species such as cattle, pig, and chicken (Hooper, Midtvedt, & Gordon, 2002; 34 
 2 
Rajesh Jha & Berrocoso, 2016; Patterson & Burkholder, 2003; Richards, Gong, & de Lange, 35 
2005; Taras, Vahjen, & Simon, 2007). However, research into the GI microbiota of aquaculture 36 
species has just recently increased. 37 
 38 
The goal of aquaculture is to produce the highest quality meat for human consumption at the 39 
lowest possible cost. To meet this goal, modulation of the GI microbiota to promote growth and 40 
health of host (fish) can be accomplished through use of probiotics, prebiotics, and alternative 41 
feed ingredients in fish diets (Burr et al., 2005; Martínez Cruz, Ibáñez, Monroy Hermosillo, & 42 
Ramírez Saad, 2012; D. Merrifield & Ringø, 2014; S. K. Nayak, 2010; Sukanta K Nayak, 2010). 43 
Probiotics are defined as live microbial feed supplements that beneficially affect the host animal 44 
by improving its intestinal microbial balance (Gibson & Roberfroid, 1995). Prebiotics are defined 45 
as non-digestible feed ingredients that beneficially affect host health by selectively stimulating 46 
the growth and/or activity of healthful bacteria and by combating undesired bacteria in the 47 
intestinal tract (Gibson & Roberfroid, 1995). Alternative feed ingredients are unconventional 48 
feed ingredients usually derived from local sources and are rich in fibre content. The fibre 49 
content of alternative feed ingredients alters the GI microbiota in a manner similar to prebiotics. 50 
The benefits of probiotics, prebiotics, and alternative feed ingredients are well documented and 51 
their use in livestock animals and human health has increased in the past decades, leading to 52 
their recent expansion into aquaculture (Burr et al., 2005; Martínez Cruz et al., 2012; D. 53 
Merrifield & Ringø, 2014; Nicholson et al., 2012). 54 
 55 
Fish health management is a primary concern in aquaculture to provide the maximum yield of a 56 
high-quality fish for human consumption (Burr et al., 2005). Historically, antibiotics were used to 57 
prevent the spread of disease in aquaculture facilities. However, recent concerns over the use 58 
of antibiotics in aquaculture led to the exploration and use of alternatives such as probiotics and 59 
prebiotics in fish diets to promote health and reduce the need for antibiotics (Defoirdt, 60 
Sorgeloos, & Bossier, 2011; Ferguson et al., 2010; L. Welker & Lim, 2011; Martínez Cruz et al., 61 
2012; S. K. Nayak, 2010; Tuan, Duc, & Hatai, 2013).  62 
 63 
Aquaculture feed is one of the primary costs in production, with fishmeal protein sources being 64 
the most expensive feed ingredient. A number of studies have been conducted to determine the 65 
optimal feed ingredients for growth and development of fishes, such as tilapia, at minimal cost 66 
( a-F. M. El-Sayed & Tacon, 1997; Mbahinzireki, Dabrowski, Lee, El-Saidy, & Wisner, 2001; D. 67 
Merrifield & Ringø, 2014; Naylor et al., 2009; Tri N. Nguyen, Davis, & Saoud, 2009; Poot-López, 68 
 3 
Hernández, & Gasca-Leyva, 2014). However, very little information is available on the effects of 69 
either conventional or alternative feed ingredients on the intestinal microbiota of aquaculture 70 
species. Of those studies available, the vast majority utilized culture-dependent techniques that 71 
overlook the facultative anaerobic microbiota in the GI tract (Burr et al., 2005; Cahill, 1990;  a-F. 72 
M. El-Sayed & Tacon, 1997; Vaughan et al., 2000). With the development of new molecular 73 
techniques, culture-independent studies of the GI microbiota of aquaculture species are 74 
providing new insights into this complex community (Sukanta K Nayak, 2010; Vaughan et al., 75 
2000). Using these techniques, researchers can now study the effects of probiotics and 76 
prebiotics on the GI microbiota of commercially important fish species to determine the most 77 
beneficial feeding strategies (Dimitroglou et al., 2011; Martínez Cruz et al., 2012; D. Merrifield & 78 
Ringø, 2014; Sukanta K Nayak, 2010; Tuan et al., 2013). Alternative feed ingredients, in 79 
conjunction with probiotics and prebiotics, may provide an optimal environment for the growth of 80 
beneficial intestinal microbiota ( a-F. M. El-Sayed & Tacon, 1997; Mbahinzireki et al., 2001; D. 81 
Merrifield & Ringø, 2014; Naylor et al., 2009; Tri N. Nguyen et al., 2009; Poot-López et al., 82 
2014). These microbiota will influence the overall health and growth of tilapia, allowing for higher 83 
yields in aquaculture (Martínez Cruz et al., 2012; D. Merrifield & Ringø, 2014). 84 
 85 
The term tilapia refers to a number of species in the Cichlidae family; however, for the purpose 86 
of this review we will focus on the three most common aquaculture species; Nile tilapia 87 
(Oreochromis niloticus), Mozambique tilapia (O. mossambicus), and the hybrid tilapia (O. 88 
niloticus × O. aureus). The farming of tilapia is the most widespread type of aquaculture in the 89 
world (FAO, 2016) and they continue to increase in popularity due to their relative ease of 90 
cultivation and their mild flavour. Production of tilapia in the year 2012 exceeded 4.5 million tons 91 
worldwide with a value of over $7.6 billion USD and subsequently continues to increase (FAO, 92 
2014). The ability to maximize production of tilapia at decreased cost will continue this upward 93 
trend while providing protein for an increasing human population. If the goal of increased 94 
aquaculture production is to continue, then an intimate knowledge of GI microbiota and their role 95 
in fish health and growth is necessary. The purpose of this review is to highlight information 96 
available on the strategies applied to modulate GI microbiota of tilapia and provide suggestions 97 
for future research with the ultimate goal of application of these strategies in aquaculture.  98 
 99 
Gastrointestinal microbiota in Tilapia 100 
Research on the GI microbiota of aquaculture species has increased in the past two decades as 101 
molecular techniques are increasingly refined and accessible (Burr et al., 2005; Sukanta K 102 
 4 
Nayak, 2010; Ray, Ghosh, & Ringø, 2012; Vaughan et al., 2000). To fully understand the need 103 
for modulation of the intestinal microbiota in tilapia culture, it is essential to review the 104 
composition and role of microbiota in growth and health of tilapia. For a review of the intestinal 105 
microbiota of fishes other than tilapia, refer to Burr et al. (2005), Cahill (1990), Gómez and 106 
Balcázar (2008), Nayak (2010a), Ray et al. (2012), Ringø et al. (2012), and Vadstein et al. 107 
(2013). 108 
 109 
Colonization and maintenance of the gastrointestinal tract by microbiota 110 
Fishes are host to a variety of microbial species on their gills and skin and throughout their GI 111 
tract. Fish are monogastric animals with a complete digestive system comprised of a mouth, 112 
pharynx, oesophagus, stomach (in most), small intestine, large intestine, pyloric caeca, liver and 113 
pancreas. Microbiota are found throughout the digestive tract; however, due to the high number 114 
of species present in the hindgut, it was concluded that these species represented active 115 
reproduction in the GI tract and not solely the ingested microflora (Cahill, 1990). A meta-116 
analysis of 25 studies of intestinal microbiota of different fish species revealed that salinity, 117 
trophic level, and possibly host phylogeny shape the composition of fish gut bacteria more than 118 
any other abiotic and biotic factor examined (Sullam et al., 2012). Del’Duca et al. (2015) 119 
determined that the bacteria present in the GI tract of tilapia fingerlings were representative of 120 
species found in the water column versus species found in the sediment. This suggests that the 121 
microbiota colonizing the intestinal tract are ingested from the water column and settle into the 122 
cecum where favourable conditions allow for their continued survival. The composition of the GI 123 
microbiota changes rapidly during the transition from the fry stage to the fingerling stage (Cahill, 124 
1990; Del’Duca, Cesar, & Abreu, 2015; Giatsis, Sipkema, Smidt, Verreth, & Verdegem, 2014; 125 
Vadstein et al., 2013). Therefore, it is necessary to begin application of diet, antibiotics, 126 
probiotics, and prebiotics from the onset of feeding in tilapia larvae to accurately determine the 127 
effect of feeds. Giatsis et al. (2014) examined the effects of different aquaculture systems on the 128 
colonization of microbiota in the tilapia fingerling intestinal tract and determined that system type 129 
(recirculating versus active suspension) accounted for the majority of the variation present in the 130 
GI tract of the larvae sampled. This suggests that water quality is the primary indicator of host 131 
microbial composition. As reviewed by Nayak (2010a), the stocking densities of tilapia and 132 
seasonal rearing conditions also have significant effects on the microbiota present in the GI 133 
tract. These are important considerations in experimental design of the investigation of tilapia GI 134 
microbiota. For the results to be applicable to the aquaculture industry, rearing conditions 135 
should mimic the stocking density and system design of aquaculture farms.  136 
 5 
 137 
Due to the challenges associated with culturing intestinal microbiota, no detailed information is 138 
available on the ecological interactions between species present in the microbiome of the tilapia 139 
GI tract (Nayak, 2010). Advances in genetics and molecular biological analyses can begin to 140 
answer these questions. For example, DNA microarrays can be used to determine expression 141 
of microbial genes in different environments present in the GI tract of fishes (Roh, Abell, Kim, 142 
Nam, & Bae, 2010; Vaughan et al., 2000). Additionally, next-generation and third-generation 143 
sequencing can be used to rapidly identify different autochthonous microbiota present in fish GI 144 
tracts and digital transcriptomics can be used to determine gene expression levels present in 145 
samples of diverse microbiota (Ekblom & Galindo, 2011; Roh et al., 2010). For a full review of 146 
advances in molecular technology and ecological applications, refer to Ekblom and Galindo 147 
(2011), Roh et al. (2010), and Vaughan et al. (2000). 148 
 149 
Common intestinal microbiota in tilapia 150 
Early investigations of the intestinal microbiota of tilapia species utilized culture-dependent 151 
techniques and were limited to identification of the most common and easily cultured species 152 
present. As reviewed by Cahill (1990), the bacteria present in the intestinal tract of tilapia 153 
included Pseudomonas sp., Virbio sp., Aeromonas sp., Enterobacteriaceae sp., and other 154 
unidentified species. A study by Molinari et al. (2003) examined the microflora in mature tilapia 155 
cultured in a semi-intensive system. They found the following bacteria present: Aeromonas 156 
hydrophila, A. veronii, Burkholderia cepacia, Chromobacterium violaceum, Citrobacter freundii, 157 
Escherichia coli, Flavimonas oryzihabitans and Plesiomonas shigelloides. Another study by 158 
Pakingking, Palma, & Usero (2015) cultured microbial species present in mature tilapia grown in 159 
earthen ponds. They identified the following heterotrophic aerobic bacteria in the tilapia 160 
intestinal tract: Aeromonas hydrophila, A. sobria, Bacillus sp., Citrobacter koseri, Edwardsiella 161 
tarda, Edwardisella hoshinae, Enterobacter cloacae, Klebsiella oxytoca, Pasteurella 162 
pneumotropica, Photobacterium damselae, Plesiomonas shigelloides, Pseudomonas 163 
aeruginosa, Pseudomonas fluorescens, Pseudomonas luteola, Pseudomonas putida, 164 
Shewanella putrefaciens, Staphyloccocus sp., Vibrio cholera, V. fluvialis, V. vulnificus, and 165 
unidentified gram-negative rod species.  166 
 167 
Recent advances in the identification of microbiota using molecular techniques have expanded 168 
our knowledge of fish microbiota ten-fold, with particular attention given to salmonids (Merrifield 169 
& Ringø, 2014; Nayak, 2010). Though many molecular studies summarized below investigate 170 
 6 
the modulation of intestinal microbiota of tilapia, to the authors’ knowledge, the first attempt to 171 
characterize the core microbiota of wild cichlid’s GI tract was only recently completed by Baldo, 172 
Riera, Tooming-Klunderud, Albà, & Salzburger (2015). Using 16S rRNA pyrosequencing of 173 
microbial DNA samples from ten cichlid species, they determined the core bacterial taxa present 174 
in at least 80% of the individuals (Table 1.1).  The species identified represent a diverse group 175 
of phyla including Actinobacteria, Bacteroidetes, Firmicutes, Fusobacteria, Planctomcetes, and 176 
Verrucomicrobia. The representative taxon from these phyla included: Cetobacterium somerae, 177 
Clostridium perfringens, Plesiomonas shigelloides, Turicibacter sp., Clostridium XI sp., 178 
Aeromonas sp., Neisseriacea, Lachnospiraceae, Clostridiales, Clostridiaceae, Gemmataceae, 179 
Acromobacter sp., Bacillus sp., and Pirellulaceae (Baldo et al., 2015). This study can be used 180 
as a baseline for intestinal modulation of microbiota in aquaculture. As discussed in section 2.1, 181 
colonization of the intestinal microbiota is highly dependent on the microbiome in the 182 
surrounding water; therefore, it is critical to include water quality and microbial analyses in the 183 
research of the intestinal microbiota.  184 
 185 
Yeast such as Saccharomyces cerevisiae are important heterotrophic fermenters in the GI tract 186 
and have been proposed as a probiotic for tilapia (Abdel-Tawwab, Abdel-Rahman, & Ismael, 187 
2008; Ayyat, Labib, & Mahmoud, 2014; He et al., 2009; Lara-Flores, Olvera-Novoa, Guzmán-188 
Méndez, & López-Madrid, 2003; D. Merrifield & Ringø, 2014). Several yeast species, including 189 
Kloeckera apiculata, Cadida sp., Metcschnikowia sp., and Rhodotorula sp., have been 190 
described in finfish other than tilapia (Gatesoupe, 2007; D. Merrifield & Ringø, 2014). Yeasts are 191 
known immuno-stimulants in fish and may promote growth and development in older fish 192 
(Gatesoupe, 2007). However, despite understanding the importance of yeast in the GI tract of 193 
fishes, no studies have investigated the naturally occurring presence or function of eukaryotic 194 
autochthonous intestinal microbiota in tilapia. 195 
 196 
Effect of microbiota on digestion, growth, and health 197 
The importance of the GI microbiota to host digestion and health were first described in humans 198 
and later investigated in commercially important livestock species such as cattle, pig, and 199 
chicken (Brisbin, Gong, & Sharif, 2008; Fouhy et al., 2012; Gibson & Roberfroid, 1995; Hooper 200 
et al., 2002; Li, Connor, Li, Baldwin Vi, & Sparks, 2012; Richards et al., 2005; Vaughan et al., 201 
2000). In the past three decades, investigations into the GI microbiota of fish have increased. 202 
These investigations have highlighted the importance of the host-microbiota interactions in the 203 
GI tract for fish growth and health. 204 
 7 
 205 
Intestinal microbiota break down non-digestible fibres that would otherwise go unutilized by the 206 
host and provide nutrients for development and growth of host. By-products of microbe 207 
metabolism including enzymes and vitamins can be absorbed along the intestinal tract and 208 
further utilized by the host. For endotherms like humans, these microorganisms provide 209 
essential enzymes for host survival; however, little information is known on the exact ecological 210 
interactions between host and microbiota in ectothermic animals like fish (Merrifield & Ringø, 211 
2014; Nayak, 2010a).  212 
 213 
In addition to host growth and development, intestinal microbiota help regulate the host immune 214 
system and overall health of the host. Gastrointestinal microbiota provide a number of benefits 215 
to host health including: development and maintenance of the mucosal membranes of the host 216 
intestinal tract; outcompete pathogenic microorganisms; aid in angiogenesis; and regulate gene 217 
expression associated with epithelial proliferation and innate immunity (Merrifield & Ringø, 218 
2014; Nayak, 2010a). With the advance of molecular techniques in recent decades, more work 219 
is needed to determine the ecological interactions between members of the GI microbiota and 220 
host-microbiota interactions in fish like tilapia. For a full review of the importance of microbiota to 221 
fish gastrointestinal tracts, refer to Nayak (2010a). 222 
 223 
Microbial pathogens 224 
In addition to beneficial microbiota in the GI tract, there are a number of pathogens competing 225 
with the autochthonous bacteria. To date, a number of pathogens invading tilapia species have 226 
been described including Streptococcus sp. (Amal & Zamri-Saad, 2011) and Francisella 227 
noatunensis subsp. orientalis (Soto et al., 2013). For a full review of disease in tilapia, refer to 228 
textbook “Health Maintenance and Principal Microbial Diseases of Cultured Fishes” by Plumb 229 
and Hanson (2011). These microorganisms represent a wide range of virulence and modes of 230 
transmission and currently there is no preventative treatment available for all pathogenic 231 
microbiota (Plumb & Hanson, 2011). For highly virulent strains that lead to massive die-offs of 232 
tilapia, antibiotics are the industry standard for treatment. However, as discussed in section 3, 233 
consumer preference is pushing aquaculture facilities to utilize preventative measures and 234 





Effects of antibiotics and their alternatives (probiotics, prebiotics, and fibrous feed 239 
ingredients) on intestinal microbiota 240 
 241 
Antibiotic effects on intestinal microbiota  242 
Antibiotics are natural or synthetic drugs used to kill or inhibit the growth of microorganisms. 243 
Their active mechanisms range from cell membrane destruction to inhibition of various 244 
metabolic pathways (Defoirdt et al., 2011; Ferguson et al., 2010; L. Welker & Lim, 2011; 245 
Martínez Cruz et al., 2012; S. K. Nayak, 2010b; Serrano, 2005; Tuan et al., 2013). For the host, 246 
antibiotics have been shown to increase intestinal absorption, digestibility of dietary protein, and 247 
potentially stimulate other metabolic processes, though it should be noted that the majority of 248 
this evidence stems from research into the porcine intestine and not the fish intestinal tract 249 
(Serrano, 2005).  250 
 251 
Despite the potential benefits of antibiotic use in aquaculture, there are a number of concerns. 252 
Due to rapid asexual reproduction in various pathogens along with the ability for acquired 253 
resistance through inter- and intra-species plasmid exchange, there is an emergence of 254 
microbial resistance to common antibiotics. Resistant microbiota can wreak havoc on 255 
aquaculture facilities while the potential for disease transmission from carcass to humans is 256 
concerning to consumers (Defoirdt et al., 2011; Ferguson et al., 2010; L. Welker & Lim, 2011; 257 
Martínez Cruz et al., 2012; S. K. Nayak, 2010b; Serrano, 2005; Tuan et al., 2013)).  258 
 259 
Another concern is the effect of antibiotics and antibiotic residues on the host. With increasing 260 
antibiotic dosage, there is the potential for increased bioaccumulation of antibiotic residues in 261 
fish tissues that may later be consumed by humans or other agriculturally important species. 262 
Depending on the antibiotic, it may act as a mutagen, allergen, toxin, or have no effect on the 263 
consumer (Serrano, 2005). Additionally, antibiotic consumption will negatively affect the host’s 264 
intestinal microbiota. As described in Section 2, intestinal microbiota are essential to 265 
mammalian growth, nutrient utilization, and health. Given the potential for negative effects on 266 
the consumer, antibiotic accumulation and potential impacts on consumers are increasingly 267 
tested and regulated. Despite these regulations, consumers are increasingly interested in 268 
“antibiotic-free” products and the market is moving away from the overuse of antibiotics that 269 
were prevalent in early aquaculture production (Defoirdt et al., 2011; Ferguson et al., 2010; 270 




Antibiotic Alternatives 274 
A number of alternatives to antibiotics proposed for tilapia and a complete review of the 275 
available alternatives to antibiotics in aquaculture is provided by Defoirdt et al. (2011). This 276 
paper reviews those antibiotics and alternatives whose effects on the intestinal microbiota of 277 
tilapia were examined in detail (Table 1.2). For more information on the development of 278 
alternatives to antibiotics in aquaculture, refer to Defoirdt et al. (2011) and the textbook 279 
“Aquaculture Nutrition: Gut Health, Probiotics, and Prebiotics” edited by Merrifield and Ringø 280 
(2014).  281 
 282 
As far as the authors are aware, the first attempt to identify the effects of antibiotics on the 283 
autochthonous intestinal microbiota of tilapia using culture-independent techniques was done by 284 
Zhou et al. (2009b). They examined the effect of feeding Potassium diformate (KDF) to hybrid 285 
tilapia (O. niloticus × O. aureus) along with three antibiotic treatments: flavomycin (8 mg/kg), 286 
quinocetone (100 mg/kg), and flavomycin (4 mg/kg) + quinocetone (50 mg/kg) over an eight-287 
week trial. The results suggested that KDF addition had no significant effect on tilapia growth 288 
performance, feed conversion ratio or survival compared to the control, but KDF treatments of 289 
3.0 and 6.0 g/kg had increased growth performance and feed conversion ratio compared to the 290 
flavomycin + quinocetone. There were changes in the GI microbiota of tilapia with increases in 291 
some species and decreases in others, which need to be investigated further in subsequent 292 
studies. A similar study by He et al. (2010) investigated the effects of the antibiotic growth 293 
promoters flavomycin and florfenicol on the autochthonous intestinal microbiota of juvenile 294 
hybrid tilapia (O. niloticus × O. aureus). They also determined that the application of antibiotics 295 
significantly decreased autochthonous bacterial diversity, with the effects of florfenicol 296 
overshadowing flavomycin. This research confirmed results from culture-dependent studies on 297 
the effects of antibiotics on GI microbiota and paved the way for systematic testing of common 298 
antibiotics and antibiotic alternatives in aquaculture.  299 
 300 
Building off this work, subsequent studies investigated the effects of: antibiotics in sequence 301 
with prebiotics such as DVAQUA® and subsequently challenged with Aeromonas hydrophila 302 
(Zhou et al., 2011); the immunostimulant Ergosan® dietary alginic acid (Merrifield et al., 2011); 303 
and the antibiotic florfenicol in combination with the amino acid derivative betaine (He et al., 304 
2012). The results from these studies were mixed: the DVAQUA® prebiotic failed to recuperate 305 
the intestinal microbiota of fish in the antibiotic treatment (Zhou et al., 2011); the dietary alginic 306 
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acid did not adversely impact the indigenous intestinal microbial balance and did not impact the 307 
epithelial brush border integrity (Merrifield et al., 2011); and florfenicol’s inhibitory effect 308 
overshadowed the beneficial effects of betaine (He et al., 2012). As Nayak (2010a) suggested, 309 
the GI microbial ecosystem dynamics are exceptionally complicated and more work needs to be 310 
done to understand the composition of the GI microbial species present, their colonization 311 
dynamics, and the interspecies interactions on one another and their host.  312 
 313 
To the authors’ knowledge, these are the only five studies so far which evaluated the effects of 314 
antibiotics on the intestinal microbiota of tilapia using culture-independent techniques. Another 315 
study investigated the effect of organic acids blend and oxytetracycline on the body mass 316 
growth, nutrient utilization, and total cultivable gut microbiota of the red hybrid tilapia and its 317 
resistance to Streptococcus agalactiae (Koh, Romano, Zahrah, & Ng, 2014). Their twenty-week 318 
trial tested three diets; 0.5% organic acids blend, 1.0% organic acids blend, and 0.5% 319 
oxytetracycline against the control diet with no additives. While oxytetracycline and the organic 320 
acids blend diets performed similarly in growth, nutrient utilization, and survival, both of the 321 
organic acids blend diets had significantly lower total faecal bacterial culture counts (Koh et al., 322 
2014). This study confirmed the effect of antibiotics on the GI microbiota of tilapia; however, 323 
they used culture-dependent techniques and thus cannot report the effect of organic acids blend 324 
and oxytetracycline on the facultative anaerobes in the tilapia intestine. Future studies should 325 
examine culture-independent techniques to fully understand the ecological interactions between 326 
species in the GI tract and the effects of antibiotics and antibiotic alternatives on the entire GI 327 
microbial community. 328 
 329 
It is known that antibiotics decrease the GI microbiota of the host and these studies attempt to 330 
highlight the specific bacterial communities affected by antibiotics, with varied results. With the 331 
increase in disease-resistant microorganisms due to the overuse of antibiotics in commercial 332 
aquaculture, it would be beneficial to determine how antibiotic alternatives affect the intestinal 333 
microbiota before their wide-scale application is considered in commercial facilities.  334 
 335 
Probiotics 336 
The vast majority of research into the intestinal microbiota of tilapia focused on the use of 337 
probiotics and their ability to survive within and benefit their host (Table 1.2). For a formal review 338 
of the probiotic research in aquaculture, refer to the following: Burr et al. (2005), Dimitroglou et 339 
al. (2011), Gómez and Balcázar (2008), Welker and Lim (2011), Martínez Cruz et al. (2012), 340 
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Nayak (2010b), and Tuan et al. (2013). To date, the following probiotics have been tested for 341 
tilapia: Bacillus sp. (Aly, Mohamed, & John, 2008; Apún-Molina, Santamaría- Miranda, Luna-342 
González, Martínez-Díaz, & Rojas-Contreras, 2009; Del’Duca, Cesar, Diniz, & Abreu, 2013; He 343 
et al., 2013), Bifidobacterium bifidum (Ayyat et al., 2014), Biogen® (El-Haroun, Goda, & Kabir 344 
Chowdhury, 2006), Chlorogloeopsis sp. (Merrifield et al., 2010), Lactobacillus sp. (Ayyat et al., 345 
2014; Jatobá et al., 2011; Liu et al., 2013; Pirarat et al., 2011), Micrococcus luteus (Abd El-346 
Rhman, Khattab, & Shalaby, 2009), Pediococcus acidilacici (Ferguson et al., 2010; Standen et 347 
al., 2013), Pseudomonas sp. (Abd El-Rhman et al., 2009), Saccharomyces cerevisiae (Abdel-348 
Tawwab et al., 2008; Ayyat et al., 2014; He et al., 2009; Lara-Flores et al., 2003; Zhou, He, et 349 
al., 2009), and Streptococcus sp. (Ayyat et al., 2014; Lara-Flores et al., 2003). All of the studies 350 
found some positive effects of the probiotics on growth, disease resistance, intestinal 351 
microbiota, and/or increased immune parameters. These results support prior studies on the 352 
importance of probiotics on intestinal microbiota, host immune response, and overall health of 353 
the host (Martínez Cruz et al., 2012; Sukanta K Nayak, 2010; Tuan et al., 2013).  354 
 355 
While the goal is to develop probiotics that are beneficial for tilapia production and health, there 356 
are vast differences in the methodologies. For example, when testing the potential of 357 
Saccharomyces cerevisiae on growth and health of tilapia fry, Abdel-Tawwab et al. (2008) 358 
chose to measure body mass growth parameters, histology, blood chemistry, bacterial colony 359 
counts using the Miles-Misra technique, and challenged the tilapia after the twelve-week trial 360 
with Aeromonas hydrophila by direct injection (Abdel-Tawwab et al., 2008). He et al. (2009) 361 
chose to investigate only the fermentation product DVAQUA® of Saccharomyces cerevisiae on 362 
juvenile hybrid tilapia over an eight week period and measured the growth of tilapia, catalogued 363 
the autochthonous bacteria by isolating V3 region of 16S rDNA using PCR-DGGE and 364 
sequencing, measured lysozyme activity, C3 and C4 serum levels, phagocytic activity index, 365 
and respiratory burst activity (He et al., 2009). While both studies conclude that Saccharomyces 366 
cerevisiae and its fermentation products are beneficial to tilapia growth and intestinal health, the 367 
optimal levels vary depending on the variables of interest.  368 
 369 
In addition, Ayyat et al. (2014) tested the effects of Saccharomyces cerevisiae in combination 370 
with Lactobacillus acidophilus, Streptococcus thermophilus, and Bifidobacterium bifidum on 371 
tilapia fingerlings. They analysed growth performance, feed efficiency, survival rate, blood 372 
protein, albumin, globulin, and plasma enzymes along with an economic analysis of the viability 373 
of each of the different treatments over the fourteen-week trial. Lactobacillus acidophilus, 374 
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Bifidobacterium bifiduim, and the mixed probiotic groups had higher survival in A. hydrophila 375 
challenge. Feed cost, return on weight gain, and profit margin increased in the highest variety 376 
probiotic group (Ayyat et al., 2014). This is the only economic analysis the authors are aware of 377 
for probiotics in tilapia to date. These three trials highlight the variety of trial designs and 378 
analyses for probiotics in tilapia aquaculture and the need for standardization of the techniques 379 
to cross-compare probiotic efficacy. In addition to standardizing techniques, it is important to 380 
study the timing of probiotic treatments, effects of probiotics on water quality and the 381 
environment, and potential pathogenic mutations of probiotic strains (Tuan et al., 2013).  382 
 383 
Prebiotics 384 
The use of prebiotics in aquaculture is an emerging field, with most research occurring over the 385 
past decade. For a full review of prebiotic use in aquaculture, refer to Burr et al. (2005) and 386 
Ringø et al. (2010). To date, the following prebiotics have been investigated for their effects on 387 
the gastrointestinal microbiota of tilapia: dietary yeast culture and short-chain fructo-388 
oligosaccharides (Zhou, et al., 2009), inulin and Jerusalem artichoke (Tiengtam, Khempaka, 389 
Paengkoum, & Boonanuntanasarn, 2015), propolis (Abd-El-Rhman, 2009), and vitamin C and 390 
inulin (Ibrahem, Fathi, Mesalhy, & Abd El-Aty, 2010). All four prebiotics increased the growth, 391 
immune response, and microbial diversity of the intestinal tract of tilapia (for those tested), 392 
confirming their beneficial effects on the overall health of the organism. To further explore their 393 
potential use in aquaculture, future experiments should consider the effects of prebiotics in 394 
conjunction with probiotics, antibiotics, and alternative feed ingredients modelled after He et al. 395 
(2012).  396 
 397 
Alternative feed ingredients and feed additives  398 
Research into alternative feed ingredients for tilapia aquaculture has primarily focused on 399 
protein, the main cost of feed production. Several reviews of alternative protein sources for 400 
tilapia have been published and the authors refer to these works for a complete description of 401 
the alternative feeds in tilapia: El-Sayed (1999), Kuhn et al. (2009), and Nguyen (2008). For the 402 
purpose of this review, the authors will focus on alternative feed ingredients and feed additives 403 
and their effects on intestinal microbiota of tilapia.  404 
 405 
The following dietary supplements and alternative feed ingredients have been investigated to 406 
determine their effect on intestinal microbiota of tilapia: the dietary supplement and phytobiotic 407 
Sangrovit® (Rawling, Merrifield, & Davies, 2009); dietary Chlorogloeopsis (Daniel Lee Merrifield 408 
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et al., 2010); and the dietary supplement NovaSil (Zychowski et al., 2013). Of these 409 
supplements, only Sangrovit® had significant effects on the growth rate and weight gain of 410 
tilapia, but no significant differences were present in the culture-dependent microbiota identified. 411 
Both Merrifield, et al. (2010) and Zychowski, et al. (2013) examined used PCR-DGGE to 412 
examine the microbial diversity in the intestinal tract of tilapia in their trials. They reported that 413 
there were no significant differences between treatments and the control, suggesting that 414 
Chlorogloeopsis and NovaSil® do not have an effect on the intestinal microbiota; however, both 415 
suggest more investigation into the microbial ecology of tilapia intestine is necessary.   416 
 417 
Recently, Pedrotti et al., (2015) examined the effect of dietary carbohydrates dextrin, ground 418 
corn, wheat, cassava bagasse, and broken rice on the intestinal microbiota of O. niloticus and 419 
Rhamdia quelen using PCR-DGGE and sequencing of the distal intestine based on their first 420 
experimental results, which indicated that more amylolytic bacteria were present in this region. 421 
They determined that the diets altered the composition of the bacterial populations present in 422 
the intestine of fish and the changes were also dependent on the species of fish (Pedrotti et al., 423 
2015). This is an important first step in the investigation of the effect of feed ingredients on the 424 
intestinal microbiota of tilapia and should be used as a model for optimizing diets containing 425 
alternative feed ingredients. 426 
 427 
Another study by Leenhouwers et al. (2008) used inocula from O. niloticus to study the in vitro 428 
fermentability of glucose, native wheat starch, arabinoxylan and whole wheat. They determined 429 
that fermentation rates were highest for glucose and lowest for whole wheat. There were vast 430 
differences in fermentability and composition of fermentation end-products between the 431 
carbohydrate sources (Leenhouwers et al., 2008). No attempt was made to culture or otherwise 432 
identify the microorganisms in the tilapia inoculum. This study focused on wheat and wheat-433 
based products as this is the primary component of commercial fish diets; however, this study 434 
could be applied to alternative carbohydrate sources and their effects on intestinal microbiota 435 
using molecular culture-independent techniques such as PCR-DGGE and next-generation or 436 
third-generation sequencing described below. 437 
  438 
Perspectives and future research considerations 439 
Over the past two decades, research into the intestinal microbiota of tilapia increased with the 440 
goal of determining optimal levels of antibiotics, alternative to antibiotics like probiotics, 441 
prebiotics, and alternative feed ingredients for tilapia diets. The research highlighted above is an 442 
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important starting point for the determination of optimal levels of antibiotics, probiotics, 443 
prebiotics, and phytobiotics along with the effects of alternative feeds on the intestinal 444 
microbiota of tilapia. However, there is still a lot of research required before a feeding regime 445 
can be designed to promote the growth, health, and quality of tilapia being raised for human 446 
consumption. 447 
 448 
Experimental design considerations  449 
The studies covered in this review vary in species and age of the tilapia, length of the study, 450 
species of bacteria used as challenge organism, and culture dependent versus independent 451 
methods, making cross-comparisons of their results exceedingly difficult. To optimize the 452 
intestinal microbiota of tilapia to promote growth, health, and quality of tilapia, the following 453 
experimental design parameters should be taken into consideration: age, research system, 454 
seasonal effects, and biotechnology techniques/applications. 455 
 456 
The first consideration is the age of tilapia species used in the study. Tilapia larvae and fry 457 
represent the colonization period for intestinal microbiota and thus are the optimal age for 458 
investigating alterations to the intestinal microbiota as preventative measure (de Blas et al., 459 
2010; Giatsis et al., 2014).  If alternative to antibiotics like probiotics, and prebiotics are 460 
considered as a treatment rather than a preventative measure, it may be beneficial to use older 461 
tilapia. 462 
 463 
Giatsis et al. (2014) investigated the colonization dynamics of intestinal microbiota in O. niloticus 464 
larvae and determined that the type of system used in research (recirculating vs. active 465 
suspension) also had a significant effect on the intestinal microbiota in the larvae. Del’Duca et 466 
al. (2015) determined that water quality also had a significant effect on the colonization of 467 
intestinal microbiota. Therefore, it would be beneficial to monitor the environmental microbiota in 468 
addition to the intestinal microbiota and compare between tanks/treatments and other test 469 
variables. 470 
 471 
In aquaculture settings, the fish are subjected to varying temperatures associated with the 472 
season, stocking densities, and water quality. However, there is little information on the effects 473 
of ecological and environmental factors on the intestinal microbiota of fishes (Wong & Rawls, 474 
2012). These effects should be investigated in more detail to determine their impact on intestinal 475 
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microbiota before determining the effects of antibiotics, prebiotics, probiotics, and alternative 476 
feeds.  477 
 478 
Finally, with the development of biotechnology applications such as microarrays and third-479 
generation sequencing, further investigation into the identification and microbial ecology of the 480 
fish intestinal tract should be the priority. Investigation into the complex interactions within the 481 
microbiome can lead to a better understanding of the interactions between intestinal microbiota 482 
and their hosts. Once these interactions are understood, then the work into the modulation of 483 
the intestinal microbiota to benefit the host can progress. 484 
 485 
Alternative feed ingredients  486 
A number of alternative feed ingredients have been evaluated for their use in tilapia aquaculture 487 
(A.-F. M. El-Sayed, 1999; Ng & Romano, 2013; Tri Niu Nguyen, 2008). The majority of these 488 
feed ingredients have been proposed as alternative protein sources to reduce costs and 489 
promote growth of tilapia. However, very few of these studies investigated the effects on 490 
intestinal microbiota. While carbohydrate sources are the primary modulator for intestinal 491 
microbiota, the shift from fishmeal to plant-based protein sources will also alter the carbohydrate 492 
composition of the diet and should be further investigated. Additionally, co-products and 493 
alternative feed ingredients rich in fibre may act as prebiotics stimulating the growth of beneficial 494 
intestinal microbiota. Due to their herbivorous nature, tilapia are capable of consuming diets with 495 
a carbohydrate content ranging from 30-40% (Mjoun Kamal, Kurt.A, & Brown Michael L., 2010). 496 
It is therefore surprising that very few of the research papers investigating the effects of 497 
proposed alternative feed ingredients have not included an intestinal microbiota analysis. 498 
 499 
Economic considerations 500 
One of the main concerns in aquaculture research is the production of high-quality products at 501 
the lowest possible cost. The vast majority of studies into the growth and health of tilapia, 502 
particularly studies on alternative feed ingredients, cited economic concerns as one of the 503 
driving factors for their work; however, relatively few of these studies reported economic 504 
analyses within their results. If the driving factor of the research is to reduce costs through the 505 
promotion of tilapia growth, health, etc., then at least a basic economic analysis should be 506 





The complex interactions in the microbiome of the tilapia gastrointestinal tract merits further 511 
research, particularly concerning the modulation of the microbiota in order to promote the health 512 
and growth of captive fish. The use of probiotics, prebiotics, and alternative feed ingredients has 513 
the potential to positively affect growth, intestinal health, nutrient digestibility, water quality, and 514 
reproduction in aquaculture and agriculture species. Special consideration should be taken in 515 
the experimental design of such applications and quantification of the microbiota in order to 516 
ensure the results are replicable in large-scale aquaculture facilities. Additionally, economic 517 
models should be applied when investigating the use of probiotics, prebiotics, and alternative 518 
feed ingredients in aquaculture. The cost-benefit analyses will provide additional criteria for 519 
commercial farms to evaluate the potential use of antibiotic alternatives in their facilities520 
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Table 1.1 Cichlid core bacterial taxa, defined by presence in at least 80% of the individuals (i.e. 20/25, excluding AstburLAB), a 521 
minimum of one representative per species and consistently in both 16S libraries (Reproduced from Baldo et al., 2015). 522 
.  523 
  524 
Phylum Class Order Family Genus Species 
Actinobacteria Actinobacteria Actinomycetales Aeromonadacea Cetobacterium Cetobacterium somerae 
Bacteroidetes Alphaproteobacteria Bacillales Clostridiaceae Clostridium Clostridium perfringens 
Firmicutes Bacilli Bacteroidales Enterocateriaceae Plesiomonas Plesiomonas shigelloides 
Fusobacteria Bacteroidia Burkholderiales Fusobacteriaceae Turicibacter  
Plactomycetes Betaproteobacteria Clostridiales Lachnospiraceae   
Proteobacteria Clostridia Fusobacteriales Neisseriaceae   
Verrucomicrobia Fusobacteria Turicibacterales Pirellulaceae   
 Gammaproteobacteria  Rhodobacteraceae   




Table 1.2 Summary of microbial analysis of dietary supplements on tilapia intestinal microbiota. 527 




Effect of Micrococcus luteus and 
Pseudomonas species isolated from the 
gonads and intestine of Nile tilapia on growth 
performance, survival rate, blood parameters 
and chemistry 
 
Best growth rate, feed utilization, and survival rate in 
diet with M. luteus 
Abd El-Rhman 





Effect of propolis on the growth rate, feed 
conversion, blood cell counts, and challenge 
by Aeromonas hydrophila  
 
Propolis-ethanolic-extract enhanced growth, 







Evaluate Saccharomyces cerevisiae as growth 
and immunity promoter in fry when challenged 
with Aeromonas hydrophila  
 
Final weight, weight gain, and specific growth rate 
increased significantly with increased yeast. Survival 
increased with yeast after injection of A. hydrophila. 
Lowest bacterial count in yeast samples vs. control.  
 
Abdel-Tawwab 




Evaluate Lactobacillus acidophilus, 
Streptococcus thermophiles, Bifidobacterium 
bifidu, and Saccharomyces cerevisiae as a 
combination probiotic in the diet of fingerlings 
using growth rate, food consumption, and feed 
conversion ratios 
 
Best growth rate, food consumption, and feed 
conversion seen in group fed probiotic “cocktail.” 
Feed cost, return on weight gain, and profit margin 
increased in probiotic cocktail group. Lactobacillus 
acidophilus, Bifidobacterium bifiduim, and cocktail 
groups had higher survival in A. hydrophila challenge 





Isolated bacteria from tilapia, sediment, and 
water. Determined potential probiotics in vitro 
and fed strains to tilapia. FISH identification of 
probiotics in GI tract of tilapia  
 
Bacillus showed most potential as probiotic in tilapia 
diet 




Effect of dietary probiotic Biogen on tilapia. 
Measured weight gain, SGR, protein efficiency 
ratio, protein productive value, energy 
retention 
 
All parameters significantly higher in diets containing 
probiotic than control 
Cost-benefit analysis suggested probiotic was 
beneficial 




Effect of Pediococcus acidilactici PCR-DGGE 
of 16S rDNA, histology of gut and blood, 
growth performance and survival 
 
Direct antagonism of gastric Pediococcus acidilactici, 
gut histology unaffected, blood leucocyte levels and 
serum lysozyme activity elevated, no change to 
growth, improved survival with Ped. Acidilactici 
 
Ferguson et al., 
2010  
Oreochromis 
niloticus  × 
Oreochromis 
aureus 
Effects of dietary saccharomyces cerevisiae 
fermentation product on growth performance, 
intestinal autochthonous bacterial community 
using DGGE 16S rDNA V3 region  
 and non-specific immunity  
 
No significant effect on growth, feed conversion, or 
survival. Variation may be due to seasonal changes. 
Enhanced nonspecific immunity 
He et al., 2009 
Oreochromis 
niloticus  × 
Effects of the antibiotic growth promoters 
flavomycin and florfenicol on the 
Flavomycin significantly altered intestinal microbiota 
Florfenicol reduced the # of autochthonous bacteria 
and overwhelmed effects of flavomycin  in diet 





autochthonous intestinal microbiota using 16S 
rDNA V3 region  
and real-time PCR 
Oreochromis 
niloticus  × 
Oreochromis 
aureus 
Effects of betaine and the antibiotic florfenicol 
on the autochthonous bacteria using 16S 
rDNA V3 region and quantitative PCR 
Betaine can promote some intestinal autochthonous 
bacteria, and florfenicol play a depressor role. When 
combined together, florfenicol may overshadow the 
effect of betaine on the predominant intestinal 
bacteria of tilapia 
 
He et al., 2012 
 
Oreochromis 
niloticus  × 
Oreochromis 
aureus 
Effects of low doses of dietary Bacillus subtilis 
C-3102 on the production, intestinal cytokine 
expression and adhesive bacteria using 16S 
rRNA V3 region and real-time PCR 
 
B. subtilis C-3102 altered the autochthonous gut 
bacterial communities, significantly increased the 
total amounts of adhesive viable bacteria, induced 
upregulation of intestinal cytokine expression (IL-1b, 
TGF-β and TNF-α) and downregulation of intestinal 
HSP70. 
 





Effect of inulin and Ascorbic acid on 
improving the performance as well as the 
immunity of Nile tilapia challenged with A. 
hydrophila 
 
Vitamin C at dose rate of 500 mg for one month 
could be a potential dietary supplement in place of 
inulin.  
 





Effect of diet supplemented with probiotic for 
Nile tilapia in polyculture system with marine 
shrimp using culture-dependent methods 
Viable heterotrophic bacterial counts decreased in 
presence of lactobacillus plantarum 









Effect of organic acids blend and 
oxytetracycline on growth, nutrient utilization, 
total cultivable gut microbiota, and resistance 
to Streptococcus agalactiae  
Similar growth and resistance to S. agalactiae, but 
significantly lower colony forming units of adherent 
gut bacteria in fish fed organic acids blend diet.   




Effect of Streptococcus faecium Lactobacillus 
acidophilus, and Saccharomyces cerevisiae 
on growth performance on fry over 9 weeks at 
various stressors – low protein and high 
stocking density 
 
The diet containing 40% protein and yeast had best 







Investigated in vitro fermentability of glucose 
(GL), native wheat starch (WS), arabinoxylan 
(ABX) and whole wheat (WHT) using inocula 
of Nile tilapia and European sea bass. 
Cumulative gas production was measured for 
168 h. At the end of incubation, fermentation 
end-products were measured. 
 
Intestinal microbes from Nile tilapia and European 
sea bass have the potential to ferment 
carbohydrates. Large differences exist in 
fermentability and composition of fermentation end 









Compare the effects of two Lactobacillus 
strains on survival and growth, adhesive gut 
bacterial communities, immunity, and 
protection against pathogenic bacteria 
No significant differences in survival rate, weight 
gain, or feed conversion. Highly adhesive 
Lactobacillus brevis showed rapid response in 
Liu et al., 2013 
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 (Aeromonas hydrophila) using PCR DGGE of 
16S rrs DNA and sequencing 
 
intestinal microbiota and appeared to protect against 




Assessment of chlorogloeopsis as a novel 
microbial dietary supplement using light and 
scanning electron microscopy for intestinal 
morphology 
PCR-DGGE 16S rRNA V3 region 
 
Highly similar microbial communities – richness and 
species diversity  
Autochthonous less diverse, dense, etc. than 
allochthonous bacteria 




Effect of dietary alginic acid on juvenile tilapia 
intestinal histology and growth performance 
using Light and scanning electron microscopy 
for intestinal morphology and PCR-DGGE 16S 
rRNA V3 region 
 
Highly similar microbial communities – richness and 
species diversity  
Non-significant elevated survival and protein content 
seen in aglinic acid group 





The effect of dietary carbohydrates on the 
autochthonous microbiota using PCR DGGE 
16S rRNA V3 region and sequencing and 
culture-dependent methods 
 
No difference in autochthonous levels among 
carbohydrate sources within species. Jundia on 
broken rice had higher culturable bacteria. Very few 
species IDs 






Modulation of intestinal morphology by 
Lactobacillus rhamnosus GG 
All parameters significantly higher in diet containing 
L. rhamnosus suggesting its value as a probiotic 
 






Preliminary assessment of dietary 
supplementation of Sangrovit® on growth 
performance and health using culture-
dependent methods 
 
Sangrovit significantly increased the final body 
weight, weight gain, mean daily feed intake, and 
specific growth rate. No significant difference in 
microbes 




Evaluate the probiotic effect of Pediococcus 
acidilactici on Nile tilapia (Oreochromis 
niloticus) intestinal health, probiotic levels, and 
system level responses using light microscopy 
and real-time PCR 
 
The probiotic has a protective action on the intestinal 
mucosal cells. These immunological modulations did 
not impair growth performance or the remaining 
haematological and zootechnical parameters 
 





Effects of inulin and Jerusalem artichoke 
(Helianthus tuberosus) as a prebiotic in 
juveniles using growth performance, blood 
chemistry, immune assay, and histology 
  
Both inulin and artichoke had significantly higher 
growth performance, red blood cell number, 
increased blood chemistry, improved immune 
activity. Both have potential as prebiotics in fish feed. 







Effects of dietary potassium diformate (KDF) 
on growth performance, feed conversion and 
intestinal bacteria using 16S rDNA PCR 
DGGE 
 
No significant effects on growth performance, feed 
conversion, or survival. However, KDF3 and KDF6 
better GP, FCR 
Positive effects on gut microbiota in KDF3 and KDF6 




Effects of dietary yeast culture (YC) or short-
chain fructo-oligosaccharides (FOS) on 
intestinal autochthonous bacterial 
Obvious effects of dietary prebiotics on intestinal 
communities. Higher variation detected within the 
dietary YC group, possibly due to the effects of 





communities in juveniles using 16S rDNA 




certain immune-stimulating agents in YC on the 






Investigate whether dietary antibiotic-induced 
changes in the fish intestinal microbiota 
altered host physiological responses to the 
infection with Aeromonas hydrophila 




Infection with A. hydrophila reduced the gut bacterial 
evenness, and slightly improved the gut bacterial 
richness in antibiotic-supplemented tilapia. A. 
hydrophila infection affected non-specific immunity 
such as serum lysozyme activity and serum 
alternative complement pathway (C3 and C4) 




Zhou et al., 2011 
Oreochromis 
niloticus 
Ability of NovaSil (NS) clay to sorb and 
mitigate the toxic effects of aflatoxin B1 
(AFB1) by monitoring growth performance, 
targeted innate immunological function, 
intestinal microbial community, and histology. 
 
Aflatoxin significantly decreased weight gain, feed 
efficiency, hepatosomatic index and macrophage 
extracellular superoxide anion production in tilapia, 
regardless of NS addition to the diet. The overall 
results regarding the efficacy of NS were mixed. No 
significant differences were found among treatment 
groups for microbial community dynamics. 







CHAPTER 2 EVALUATION OF MORINGA STENOPETALA LEAVES AS A PREBIOTIC IN 531 
HYBRID TILAPIA PRODUCTION 532 
 533 
Abstract 534 
Prebiotics have increasingly been used in aquaculture to promote health. Moringa (Moringa 535 
stenopetala) is an East-African tree used primarily for food but is known to contain medicinal 536 
benefits. Moringa leaves are rich in fiber, thus they may serve as a prebiotic. This study 537 
investigated the role of moringa leaves as a prebiotic in hybrid tilapia (Oreochromis niloticus × 538 
O. mossambicus) production. Four hundred tilapia fingerlings (7.1 ± 0.55g initial body weight) 539 
were divided between 16 tanks and fed with one of the four diets with the following inclusion 540 
levels of moringa leaves: 0% (control), 6%, 9%, or 12% for 84 days. The specific growth rate, 541 
feed conversion ratio, protein efficiency ratio, and percent survival were recorded over the 542 
course of the study. Intestinal samples were collected monthly and subjected to microbiota 543 
characterization using PCR-DGGE and metagenomic sequencing. The results indicate that 544 
inclusion of moringa leaves altered the intestinal microbiota of tilapia, particularly the increase in 545 
Caulobacteraceae, Oxalobacteraceae, and Comamonadaceae, suggesting that it may be used 546 
as a prebiotic in tilapia aquaculture. Additionally, the reduction in proteobacterial levels suggests 547 
that M. stenopetala may have anti-inflammatory properties, similar to those recorded in M. 548 
oleifera. 549 
 550 




The intestinal microbiome is a complex set of interactions between microbes and their host. The 555 
mutualistic relationship between the host and its intestinal microbiota determines the overall 556 
health, and thus the evolutionary fitness of the host. Microbes help regulate the digestive 557 
processes, immune system, and even brain function of the host; therefore, understanding their 558 
function and modes of action are critically important to promoting the health and well-being of 559 
humans and food animals through the use of prebiotics (Fouhy, Ross, Fitzgerald, Stanton, & 560 
Cotter, 2012; Giatsis, Sipkema, Smidt, Verreth, & Verdegem, 2014; Gibson & Roberfroid, 1995; 561 
Haygood & Jha, 2018; Hooper, Midtvedt, & Gordon, 2002; Jha & Berrocoso, 2016; Llewellyn, 562 
Boutin, Hoseinifar, & Derome, 2014; Nicholson et al., 2012; Round & Mazmanian, 2009).  563 
 564 
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Prebiotics are non-digestible food ingredients that beneficially affect the host by selectively 565 
stimulating the growth and/or activity of one or a limited number of bacterial species already 566 
residing in the colon, and thus attempt to improve host health (Gibson & Roberfroid, 1995). A 567 
number of prebiotics have been investigated for human consumption (Gibson & Roberfroid, 568 
1995; Reid et al., 2003; Roberfroid, 2007) and food animal consumption (Burr et al., 2005; 569 
Haygood & Jha, 2018; Patterson & Burkholder, 2003; Ringø et al., 2010) to promote their 570 
overall health. While Moringa oleifera has been studied for its anti-cancer (Gopalakrishnan, 571 
Doriya, & Santhosh Kumar, 2016; Kooltheat et al., 2014; Sreelatha, Jeyachitra, & Padma, 2011; 572 
Tiloke, Phulukdaree, & Chuturgoon, 2013; Vasanth, Ilango, MohanKumar, Agrawal, & Dubey, 573 
2014), anti-inflammatory (Kooltheat et al., 2014), and water purification properties (Desa, 2010), 574 
no work has been done on M. stenopetala in this regard. Moringa stenopetala is easily 575 
cultivated in tropical and subtropical climates, even in marginal conditions. It is currently 576 
consumed as an important dry season vegetable and used as alternative medicine in different 577 
parts of the world (Bennett et al., 2003). Moringa leaves are high in crude fiber, crude protein, 578 
calcium, vitamin C, β-carotene, and produce secondary metabolites like flavonoids that are 579 
beneficial for the host intestinal tract (Gopalakrishnan et al., 2016; Imungi et al., 2011; Melesse, 580 
Bulang, & Kluth, 2009; Richter, Siddhuraju, & Becker, 2003).  Crude fiber and vitamin C have 581 
been shown to modulate the intestinal microbiota in humans and food animals (Ibrahem, Fathi, 582 
Mesalhy, & Abd El-Aty, 2010; Jha & Berrocoso, 2016; Queiroz-Monici, Costa, Da Silva, Reis, & 583 
De Oliveira, 2005). It has been shown in humans and swine that inclusion of dietary fiber and 584 
reduction of crude protein in diets may counteract the negative effects of protein fermentation in 585 
the gut by reducing ammonia concentration and shifting nitrogen excretion pathways in the gut 586 
(Gibson & Roberfroid, 1995; Jha & Leterme, 2012; Jha & Berrocoso, 2016). These factors make 587 
Moringa leaves a potential prebiotic for human and food animals. 588 
 589 
The purpose of this study was to evaluate the effect of dietary inclusion of Moringa stenopetala 590 
leaves on the intestinal microbiome using tilapia as a host species. Our hypothesis was that the 591 
incorporation of moringa leaves in tilapia diets will significantly alter the intestinal microbial 592 
composition.  593 
 594 
Materials and methods 595 
All animal procedures were conducted in accordance with the approval (protocol #13-1639) 596 
from the Institutional Animal Care and Use Committee (IACUC) of the University of Hawaii, 597 
Honolulu, HI, USA. 598 
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 599 
Feeding trial 600 
Four hundred fingerling tilapia (Oreochromis niloticus x O. mossambicus) with an initial weight 601 
of 7.1 ± 0.55g were randomly and equally allocated to one of four treatments with four replicate 602 
freshwater tanks each (experimental unit). Four moringa leaves diets (inclusion levels: 0, 6, 9, 603 
and 12%) were offered twice daily up to 4 percent body weight daily. Water quality parameters 604 
(pH, nitrates, nitrites, ammonia, temperature, and dissolved oxygen, DO) were monitored 605 
weekly to ensure they were within the optimal range for tilapia. The DO concentration, 606 
temperature, and pH were measured routinely using the HQ40d Portable Water Quality Lab 607 
Package (Hach, Loveland, CO, USA). Total ammonia nitrogen (TAN, NH3-N) was measured 608 
using the reaction kit Ammonia TNTplus, ULR (TNT 830, Hach, Loveland, CO, USA). Nitrite-N 609 
(NO3-N) was measured using the reaction kit Nitrite TNTplus, LR (TNT 839, Hach, Loveland, 610 
CO, USA). Nitrate-N (NO2-N) was measured using the reaction kit Nitrate TNTplus, HR (TNT 611 
836, Hach, Loveland, CO, USA). Water temperature was maintained at 22.5±0.8oC, DO was 612 
maintained at 10.7±0.7 mg/L, pH was 7.9±0.25, NH3-N was 3.4±3.6 ppm, NO3-N was 2.97±2.0 613 
ppm, and NO2-N was 12.4±22.7 ppm. A 12 h light ⁄ 12 h dark photoperiod was maintained 614 
throughout the animal study period. 615 
  616 
Experimental diet 617 
Moringa stenopetala were harvested from the University of Hawaii Waimanalo Research Station 618 
(Waimanalo, HI, USA). The sample was ground to pass through a 1.0 mm-mesh screen using a 619 
laboratory mill and dried in an air-dry oven. The ground sample was subjected to proximate 620 
analysis according to the Association of Official Analytical Chemists standard procedures 621 
(AOAC, 2007) with specific methods as follows: DM (135°C for 2 h, AOAC 930.15); Crude 622 
protein (CP) analysis (AOAC 976.05) by determining nitrogen (N) using LECO TruSpec CN 623 
analyzer (LECO Corp., St. Joseph, MI, USA) and N multiplied by 6.25 to get the % CP; crude 624 
fiber (AOAC 978.10), crude fat (AOAC 920.39; using Soxhlet apparatus and petroleum ether), 625 
and ash (AOAC 942.05). Vitamin C analysis was performed on the moringa leaf samples 626 
(AOAC 967.22). Four isocaloric and isonitrogenous diets were formulated to meet the nutritional 627 
requirements of tilapia fry (Mjoun Kamal et al., 2010). All diets were analyzed following the 628 
same methods as moringa leaf samples (described above); the ingredient composition and 629 




Intestinal microbiota and environmental microbiota sampling 633 
Tilapia intestinal microbiota was sampled monthly and the intestinal samples from two fish per 634 
tank were pooled (four samples per treatment). The fishes were euthanized with 0.6 g l-1 635 
Tricaine Methanesulfonate (TMS, Crescent Research Chemicals, Phoenix, AZ, USA), buffered 636 
with 0.12 g l-1 sodium bicarbonate in water originating from the corresponding rearing tank. 637 
Subsequently, fish were rinsed with 70% ethanol and sterile water before dissecting out 638 
aseptically the gut under a dissection microscope. Whole gut samples were flash frozen in liquid 639 
nitrogen and stored individually at -80oC until subsequent analyses. DNA extraction followed the 640 
protocol outlined previously (Yu & Morrison, 2004). Microbial DNA was analyzed as outlined 641 
below. 642 
  643 
PCR-DGGE 644 
PCR amplification of the 16S rRNA V3 region was conducted with universal primers U2 and U3 645 
and a 40-60% DGGE analysis were conducted as described by Merrifield et al. (2010) (Daniel 646 
Lee Merrifield et al., 2010). Dendrograms were created from the DGGE results using ImageJ 647 
software.  648 
 649 
16S rRNA gene sequencing analysis 650 
Metagenomic analysis of the 16S rRNA V3 and V4 regions were conducted using the Illumina 651 
MiSeq system. The following primers were used prior to sequencing (in standard IUPAC 652 
nucleotide nomenclature): 16S Amplicon PCR Forward Primer = 653 
5'TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG 654 
16S Amplicon PCR Reverse Primer =  655 
5'GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC 656 
The quality of the reads was determined using FastQC and trimmed with Prinseq. QIIME was 657 
used for metagenomics quality control and taxon classification and quantification. DESeq2 was 658 
used for the differential abundance analysis of the operational taxonomic units (OTUs) 659 
identified. Krona charts (Ondov, Bergman, & Phillippy, 2011) were generated from the 660 
sequences using the MG-RAST server (Glass & Meyer, 2011) to illustrate the composition of 661 
intestinal microbiomes of tilapia fed different inclusion levels of moringa. 662 
 663 
Statistical Analysis 664 
The data were analyzed using DESeq2 analysis of deviance (ANODEV) and pair-wise 665 
comparisons between treatments. Significance was considered at P <0.05. For diversity 666 
 30 
measures, Shannon Diversity Index was calculated for alpha diversity, and Bray-Curtis was 667 
used to compare beta diversity along with a principal coordinates analysis. 668 
  669 
Results  670 
The analyzed nutrient composition (as fed basis) of Moringa stenopetala leaves was found to be 671 
as follows: DM 82.81%, Ash 8.60%, Crude Protein 24.50%, Crude Fat 5.36%, Crude Fiber 672 
7.36% and Vitamin C 152mg. Survival, growth rate, feed conversion ratio, protein efficiency ratio 673 
of tilapia were not significantly different between treatments (data not presented). The mean 674 
percent survival was 94-98% per treatment.  675 
 676 
Intestinal Microbiota from PCR-DGGE Results 677 
Intestinal microbiota samples were different between samples, as shown in Figure 2.1, with the 678 
highest diversity in the Control and 9% moringa treatments (Table 2.3). However, based on the 679 
clustering patterns in the dendrogram (Figure 2), there were no obvious differences between 680 
treatments. 16S rRNA gene sequencing analysis was conducted to further elucidate any 681 
differences in the intestinal microbiome. 682 
  683 
Intestinal Microbiota from Metagenomic Results 684 
Table 2.2 provides a summary of the various bacterial families identified in the 16S rRNA gene 685 
sequencing analysis. Of the different families present in the results, 10 have never been 686 
reported in tilapia intestinal contents before, to the best of the author’s knowledge. These 687 
families include: Bryobacteraceae (2017), Corynebacteriaceae (1986 – dyptheria and human 688 
saliva), Microbacteriaceae (soil), Propionibacteriaceae (very little known intestinal microbe), 689 
Cytophagaceae (found in environmental samples previously), Weeksellaceae (insect intestine 690 
and very little else known), Sphingobacteriaceae (Soils and composts – decomposers), 691 
Xanthobacteraceae (2005 chemoheterotrophs), Alteromonadaceae (marine), and 692 
Chromatiaceae (purple sulfur bacteria).  693 
 694 
Intestinal microbiota varied among treatments, as shown in Figures 2.2, 2.3, and 2.4 and Table 695 
2.2. The initial microbiota samples most closely resembled the control (0% moringa) group in 696 
the patterns of bacterial orders present. Overall alpha-diversity was not significantly different 697 
among treatments (Table 2.3 and Figure 2.4). However, based on the pairwise comparisons 698 
and the ANOVA, several microbial groups were significantly different between the moringa and 699 
control groups. 700 
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 701 
As shown in Figure 2.2, the dominant bacterial phyla present were Proteobacteria, Bacteroides, 702 
and Actinoids. From the pairwise comparisons (Table 2.4), it was clear that the family 703 
Caulobacteraceae was significantly different (P <0.05) between the control and the 9% moringa 704 
treatment, making up 7% of the OTUs in this treatment. The Oxalobacteraceae family was 705 
significantly different between the control (0% moringa) and the treatments (6, 9, and 12% 706 
moringa). Oxalobacteraceae was not present in the 0% treatment and was highest in the 6% 707 
and 12% treatments, representing 7% of the OTUs in these treatments. The family 708 
Comamonadaceae was significantly different between the control and 6% treatment, making up 709 
15% of the OTUs in this treatment. The phylum Proteobacteria was significantly different (P < 710 
0.001) between treatments, with the highest average number of OTUs in the initial sample 711 
(3259) and the lowest average OTUs in the 12% moringa inclusion sample at the end of the 712 
study (939).  713 
 714 
Discussion 715 
A study by Richter et al. (2003) showed that M. oleifera leaves could be incorporated as a 716 
fishmeal replacement for tilapia up to 10% of the diet without negative effects on growth. In the 717 
current study, M. stenopetala leaves were incorporated into the diet of hybrid tilapia up to 12% 718 
without adverse effects on growth and survival of the fish.  719 
 720 
To the best of the author’s knowledge, ten of the families of microbes identified in the intestinal 721 
tract of tilapia in this study have never been reported previously. Two of these families have 722 
been recently described based on their 16S rDNA sequences: Bryobacteraceae in 2017 and 723 
Xanthobacteraceae in 2005 so little research has been done on their role in the intestinal 724 
microbiome. Microbacteriaceae, Cytophagaceae, and Sphingobacteriaceae are soil microbes 725 
that decompose organic material and may either be a product of remaining food particles in the 726 
intestine or new decomposers in the tilapia intestinal tract.  Xanthobacteracea are 727 
chemoheterotrophic bacteria that have not been previously reported in the intestinal tract of 728 
animals. Chromatiaceae are purple sulfur bacteria, and Alteromonadaceae are marine microbes 729 
that require sodium as a large component of their metabolism. Finally, Corynebacteriaceae, 730 
Propionibacteriaceae, and Weeksellaceae are all intestinal microbes that are found in humans, 731 
other vertebrates, and insects, respectively. The role of these microbial families in the tilapia 732 
intestinal microbiome is unknown at this time. 733 
 734 
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Based on the pairwise comparisons and the ANOVA of the metagenomic results, several 735 
microbial groups were significantly different between the moringa and control groups. Therefore, 736 
Moringa stenopetala does alter the intestinal microbiota of tilapia. 737 
 738 
Previous research stated that Firmicutes were the vast majority of bacteria present in the tilapia 739 
samples (Rodiles et al., 2015); however, as shown in Figure 2, the dominant bacterial phyla 740 
present were Proteobacteria, Bacteroides, and Actinoids, which is similar to a recent work done 741 
in a biofloc system (Kathia, Cienfuegos Martinez, del Carmen, Monroy Dosta Maria, Aida, 742 
Hamdan Partida, Jorge, Castro Mejia, Feliz, Aguirre Garrido Jose, Amadeo, 2018). This may be 743 
due to the environment and host intestinal ecology of the stock fish raised in Hawaii and kept in 744 
a recirculating aquaculture system (Richards et al., 2005; Wong & Rawls, 2012).  745 
 746 
The results show a number of significant differences between the control (0% moringa) and the 747 
treatment diets (6, 9, and 12% moringa). Oxalobacteraceae was not present in the 0% 748 
treatment and was highest in the 6% and 12% treatments, representing 7% of the OTUs in 749 
these treatments. Oxalobacter formigenes is known to reduce the incidence of kidney stones in 750 
humans (Dretler et al., 2008). More work is required to determine the effect of increased 751 
Oxalobacteraceae numbers in diets that contain moringa on human and other vertebrate 752 
intestinal microbiomes.  753 
 754 
The family Comamonadaceae was significantly different between the control and 6% treatment, 755 
making up 15% of the OTUs in this treatment. Comamonadaceae abundance is correlated with 756 
the ileum IL17 and RORyt mRNA concentration in mice fed high fat diets which led to improved 757 
glucose tolerance and fat/lean ratio (Garidou et al., 2015), again suggesting that more research 758 
is needed into the effect of Moringa stenopetala on intestinal microbes and their ability to affect 759 
metabolic diseases such as diabetes and growth and health of fish. 760 
 761 
The phylum Proteobacteria was significantly different (P < 0.001) between treatments, with the 762 
highest average number of OTUs in the initial sample (3259) and the lowest average OTUs in 763 
the 12% moringa inclusion sample at the end of the study (939). Proteobacteria have been 764 
linked to intestinal inflammation and dysbiosis in humans (Mukhopadhya, Hansen, El-Omar, & 765 
Hold, 2012; Shin, Whon, & Bae, 2015); therefore, the inclusion of moringa into tilapia diets may 766 
also reduce the proteobacterial load and reduce inflammation, lowering overall costs of tilapia 767 
production by reducing health-related costs associated with their production. The closely related 768 
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species Moringa oleifera has already been shown to be an anti-inflammatory agent in humans 769 
(Gopalakrishnan et al., 2016; Kooltheat et al., 2014), so it is likely that M. stenopetala may have 770 
a similar effect. However, more work should be done to investigate the potential anti-771 
inflammatory effects of M. stenopetala. 772 
 773 
In conclusion, Moringa stenopetala inclusion into the diets of tilapia significantly altered the 774 
intestinal microbiome, suggesting that it may be used as a prebiotic in aquaculture. The 775 
reduction in proteobacterial levels in the intestine of tilapia suggests that M. stenopetala may 776 
have anti-inflammatory properties similar to M. oleifera.  Future studies should investigate the 777 
anti-inflammatory properties of M. stenopetala by investigating the histological effects of 778 
moringa in the diets of tilapia.   779 
  780 
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Table 2.1 Ingredient composition and nutrient content of diets fed in the study 781 
Item Diets 
Control 6% Moringa 9% Moringa 12% Moringa 
Ingredient, g/kg     
Soybean meal (45% CP) 100.0 100.0 100.0 100.0 
Moringa leaf  - 60.0 90.0 120.0 
Corn 185.4 180.9 143.9 116.9 
Fish and meat meal 200.0 200.0 200.0 200.0 
Profine®1 250.0 230.0 220.0 210.0 
Cassava flour 180.0 150.0 190.0 200.0 
Soybean oil 10.0 10.0 - - 
Molasses 20.0 20.0 10.0 10.0 
Lysine 12.0 9.0 7.0 5.0 
Methionine 4.0 3.5 3.0 3.0 
Threonine 3.5 1.5 1.0 - 
Choline chloride 15.0 15.0 15.0 15.0 
Phytase 0.10 0.10 0.10 0.10 
Vitamin mix 10.0 10.0 10.0 10.0 
Mineral mix 10.0 10.0 10.0 10.0 
Analyzed composition (as fed, g kg-1) (n=3) 
Dry matter 89.03 89.12 88.73 88.58 
Ash 6.43 7.18 7.19 7.44 
Crude protein 33.57 34.15 33.64 33.5 
Crude fat 5.74 6.56 5.28 5.16 
Crude fiber 6.43 4.53 5.01 4.89 
NDF 11.40 13.53 11.00 13.52 
ADF 4.77 5.81 5.92 7.01 
Vitamin C 96.4 105.3 136.8 163.2 
Gross energy (kcal/kg) 3205 3217 3226 3267 
1. Profine® Powdered Soy Protein Concentrate was purchased from the DuPont® Feed company, Wilmington, DE, USA 782 
Ingredients are expressed as g per kg-1 diet. Dietary codes: 6% = 6% moringa inclusion; 9% = 783 
9% moringa inclusion; 12% = 12% moringa inclusion. 784 
  785 
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Table 2.2 List of bacterial genera and their corresponding sample presence. Samples are taken 786 
from the intestine of hybrid tilapia fed either 0, 6, 9, or 12% ground moringa leaf inclusion in the 787 
diet or from the initial tilapia samples prior to experimental feeding.  788 
 789 
Phylum Class Order Family Genus Samples 
Acidobacteria Soilbacteres Soilbacterales  Bryobacteraceae Unknown 6, 9, 12% 








Unknown 6, 9, 12% 







Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides Initial 
Cytophagia Cytophagales Cytophagaceae Unknown 6, 9, 12% 
Emticicia 6% 
























0, 6, 9, 
12% 
Saprospiraceae Unknown 0, 6, 9% 
Haliscomenobac
ter 
0, 9, 12% 
Chlorobi OPB56 Unknown Unknown Unknown 6, 9, 12% 
Cyanobacteria Unknown Unknown Unknown Unknown 0, 6% 
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Firmicutes Clostridia Clostridiales Unknown Unknown 0, 6, 9% 
Initial 





Planctomycetia Gemmatales Isosphaeraceae Unknown 0, 9, 12% 
Pirellulales Pirellulaceae Unknown 0, 12% 
Proteobacteria Alphaproteobac
teria 




Asticcacaulis 6, 9% 
Caulobacter 6, 9, 12% 
Mycoplana Initial 
Rhizobiales Unknown Unknown 0, 6, 12%, 
Initial 
Rhizobiaceae Shinella Initial 
Xanthobacterace
ae 
Ancylobacter 6, 9, 12% 
Rhodobacterales Rhodobacterace
ae 


















Burkholderia 0, 9% 
Comamonadace
ae 










Cellvibrio 0, 6, 9, 
12% 
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Legionellales Unknown Unknown Initial 
Pseudomonadal
es 




















Unknown 9, 12% 
 790 
 791 
  792 
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Table 2.3 Shannon Diversity Index results for the 16S rRNA gene sequencing analysis of the 793 
intestinal microbiota of tilapia fed diets containing different inclusion levels of moringa (0%, 6%, 794 
9%, 12%). Initial microbiota analysis was included for comparison. 795 
Treatment Bacterial Orders Reads H’ 
Initial 21 6260 2.62 
0% 27 5603 2.97 
6% 20 7397 2.49 
9% 23 9125 2.94 
12% 21 8712 2.37 
 796 
  797 
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Table 2.4 Pairwise comparisons of microbial diversity between the control group (0% moringa 798 
inclusion) and the treatments (6%, 9%, 12% moringa inclusion). Only significant differences are 799 
reported here. For a full list of microbial orders present in the samples, see Table 5 and Figure 800 
4. 801 
Treatment Family 0% OTU Treatment OTU Significance 


















12% Moringa Oxalobacteraceae 0 323 <0.001 
 802 
 803 




Figure 2.1 PCR-DGGE Dendrogram results of intestinal microbiota from diets with different 807 
inclusion levels of moringa: Initial (Initial microbiota samples before feeding); 0% (Control with 808 
no moringa inclusion): 6% moringa inclusion; 9% moringa inclusion; and 12% moringa inclusion. 809 
 810 
  811 
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    812 
   813 
Figure 2.2 Krona Charts of Bacterial Family Diversity in the microbiota of hybrid tilapia fed 814 
different treatment diets: Control (0% Moringa, A), 6% Moringa (B), 9% Moringa (C), 12% 815 








Figure 2.3 Relative frequency of bacterial orders per treatment highlighting the different 823 
microbiota present with varying moringa inclusion levels (0, 6, 9, and 12%) in hybrid tilapia diets 824 





Figure 2.4 Alpha Diversity of treatments using Faith’s Phylogenetic Diversity. Kruskal Wallis 829 
results showed no significant differences between treatment alpha diversity. 830 
 831 
  832 
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CHAPTER 3 CASSAVA CHIPS AS A PREBIOTIC IN TILAPIA AQUACULTURE 833 
 834 
Abstract 835 
In order to increase aquaculture production while reducing production costs, alternative 836 
ingredients must be investigated to reduce the dependency on conventional energy sources in 837 
aquaculture feeds. Like prebiotics, feed ingredients with high fiber and resistant starch also 838 
modulate the intestinal microbiota of the host while providing nutritional value for growth 839 
performance. Tilapia (Oreochromis sp.) are the most widespread aquaculture species in the 840 
world due to their relative fecundity, omnivorous feeding habits, and tolerance of marginal 841 
growing conditions, making them ideal study species for alternative feed ingredients. This study 842 
investigated the use of sun-dried cassava (Manihot esculenta) chips as corn replacement to 843 
reduce feed cost while maintaining production levels of hybrid tilapia (O. niloticus x O. 844 
mossambicus). Four hundred tilapia fingerlings (~10g initial body weight) were randomly and 845 
equally placed in 20 tanks and fed with one of the 5 diets with 0, 4.38, 8.75, 17.5, and 26.25% 846 
cassava inclusion in basal diets for 12 weeks. Feed intake and body weight was recorded 847 
weekly and intestinal samples were collected monthly and processed for microbiota analysis 848 
using PCR-DGGE and 16S rRNA gene sequencing analysis. Tilapia growth performance was 849 
not significantly different among treatments (P>0.05), suggesting that cassava can be 850 
incorporated up to 26.25% into the tilapia diets without negative impact. Additionally, cassava 851 
inclusion into the tilapia diets significantly altered the intestinal microbiota, which can be used as 852 
a strategy to modulate gut health of Tilapia. 853 
 854 
Keywords: Cassava, Microbiota, Intestinal Microbiome 855 
 856 
Introduction 857 
Aquaculture feed is one of the primary costs in production and a number of studies have been 858 
conducted to determine the optimal feed for growth and development of aquatic animals, such 859 
as tilapia, at minimal cost. Tilapia (Oreochromis sp.) is the second most farmed fish group 860 
worldwide and over the past decade has quadrupled in production, largely due to their many 861 
characteristics conducive to aquaculture conditions as well as to the high marketability and 862 
relatively stable market prices (Ng & Romano, 2013). Production of tilapia in 2015 exceeded 5.7 863 
million tons worldwide with a value of over $9 billion USD and has continued to subsequently 864 
increase (FAO, 2016). The ability to maximize production of tilapia at decreased cost will 865 
continue this upward trend while providing protein for an increasing human population.  866 
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 867 
Corn is the major feed ingredient, providing energy in the diets of tilapias. Its diverse uses in 868 
food, feed, and biofuel production has led to variability in cost and availability. Thus, it is 869 
imperative to explore and evaluate alternative feed ingredients to replace corn in the fish diets 870 
for sustainable and cost-effective fish production. Cassava (Manihot esculenta) is one 871 
alternative to corn, as it is rich in starch content. It is available globally with 70% of the 872 
production coming mostly from Tropical countries like from Nigeria, Brazil, Thailand, Indonesia, 873 
and the Democratic Republic of the Congo. Production levels in 2017 were projected at 278 874 
million tons worldwide, with the majority of international flow confined to East and Southeast 875 
Asia (FAO, 2015). Cassava root chips are rich in carbohydrate content, and thus may be used 876 
as a prebiotic in aquaculture. However, it is a poor source of protein and contains anti-nutritional 877 
factors like cyanogenic glucosides, linamarin, and lotaustralin, which on hydrolysis yield 878 
hydrocyanic acid (HCN). HCN toxicity might be limiting factor of using cassava in fish diets 879 
(Oke, 1978). The HCN in cassava can be considerably reduced to the acceptable limit by 880 
boiling, drying, grating, soaking, fermentation, or combination of these processes (Chhay, Borin, 881 
Sopharith, Preston, & Aye, 2010; Ravindran, 1993). Cassava, having a high moisture content, is 882 
usually dried in the sun. Sun drying is also a more cost-effective and energy efficient method as 883 
compared to oven-drying. Moreover, sun drying is more effective than oven-drying at reducing 884 
the HCN level of cassava chips (Mestres & Rouau, 1997), which is a major concern of using 885 
cassava in animal diets. There is also variation in the nutrient profile of cassava chips due to 886 
several factors including type of cassava and agro-climatic condition where it was grown 887 
(Coursey & Halliday, 2017; Mestres & Rouau, 1997; Oke, 1978; Ravindran, 1993). 888 
 889 
Animal scientists advocate for the use of cassava root and byproducts in animal feeding 890 
programs due to the ease of cultivation, particularly in dry climates (Coursey & Halliday, 2017; 891 
Lukuyu, Okike, Duncan, Beveridge, & Blümmel, 2014). Previous studies utilizing cassava in 892 
tilapia feed have found inclusion levels of around 10% allow for the maintenance of production 893 
levels without deleterious health effects on the tilapia (Chhay et al., 2010; Sena et al., 2012; 894 
Tram, Ngoan, Hung, & Lindberg, 2011). Some of the researches have also shown positive 895 
results with inclusion up to 50% (Lukuyu et al., 2014). Cassava is rich in carbohydrates, 896 
particularly starches, and can provide energy and protein for tilapia. It is also currently used as a 897 
binder in many feeds (Coursey & Halliday, 2017).  898 
 899 
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The intestinal microbiota of fish are directly impacted by the feed ingredients used in the fish 900 
diet, particularly the carbohydrate sources (Haygood & Jha, 2018; Rurangwa et al., 2009; Tran-901 
Duy, Smit, van Dam, & Schrama, 2008). Nondigestible feed ingredients are known as prebiotics 902 
and can alter the intestinal microbiome of the host that consumes them. This can provide host 903 
benefits including: modulation of blood lipid levels, gastrointestinal and systemic 904 
immunomodulation, provide energy for intestinal cell proliferation, and improve intestinal barrier 905 
function, among other benefits (Dimitroglou et al., 2011; Haygood & Jha, 2018; Llewellyn et al., 906 
2014; Sukanta K Nayak, 2010; Roberfroid, 2007). Cassava is known for its high starch content 907 
and provides a number of prebiotic ingredients for tilapia microbiota (Chhay et al., 2010; 908 
Coursey & Halliday, 2017; Pedrotti et al., 2015b; Sena et al., 2012; Tram et al., 2011) 909 
 910 
The effect of cassava on the intestinal microbiome of tilapia has been studied using culture-911 
based and PCR-DGGE techniques, but to the authors’ knowledge, there have not been any 912 
studies investigating the effect of cassava on the microbiome using next-generation sequencing 913 
methods. The purpose of this study was to evaluate the effect of dietary inclusion of Manihot 914 
esculenta sun-dried chips on the intestinal microbiome in hybrid tilapia. We hypothesized that 915 
the incorporation of cassava chips in tilapia diets will significantly alter the intestinal microbial 916 
composition.  917 
 918 
Materials and methods 919 
All animal procedures were conducted in accordance with the approval (protocol #13-1639) 920 
from the Institutional Animal Care and Use Committee (IACUC) of the University of Hawaii, 921 
Honolulu, HI, USA. 922 
 923 
Preparation of Cassava chips  924 
Locally produced and processed (sun dried) cassava root chips with peel were used in this 925 
study. The cassava chips were ground through sieve size of 3/16. Prior to diet formulation, 926 
proximate and other nutrient composition of cassava chips were determined. The nutrient profile 927 
was used from a previous study conducted in our lab.  928 
 929 
Feeding trial 930 
A total of 400 tilapia (~20-30g) were randomly and equally allocated into the 20 freshwater tanks 931 
(20 fish per tank) located at Magoon research facility of UH Manoa. Each tank was labeled 932 
randomly as one of the five dietary experimental groups. During the acclimation period of 7 933 
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days, all tilapia were offered the control diet twice a day (8 am and 4 pm) up to 5% of their body 934 
weight per day. During the experiment period, tilapia were fed the formulated diets by hand 2 935 
times a day (8 am and 4 pm) up to 5% of their body weight per day every day for 84 days. 936 
Water quality parameters (nitrates, nitrites, ammonia, pH, temperature, dissolved oxygen) were 937 
measured weekly before feeding and maintained to have healthy water quality.  938 
 939 
Water Quality  940 
Water quality parameters (pH, nitrates, nitrites, ammonia, temperature, and dissolved oxygen, 941 
DO) were monitored weekly to ensure they were within the optimal range for tilapia. The DO 942 
concentration, temperature, and pH were measured routinely using the HQ40d Portable Water 943 
Quality Lab Package (Hach, Loveland, CO, USA). Total ammonia nitrogen (TAN, NH3-N) was 944 
measured using the reaction kit Ammonia TNTplus, ULR (TNT 830, Hach, Loveland, CO, USA). 945 
Nitrite-N (NO3-N) was measured using the reaction kit Nitrite TNTplus, LR (TNT 839, Hach, 946 
Loveland, CO, USA). Nitrate-N (NO2-N) was measured using the reaction kit Nitrate TNTplus, 947 
HR (TNT 836, Hach, Loveland, CO, USA). Water temperature was maintained at 22.5±0.8oC, 948 
DO was maintained at 10.7±0.7 mg/L, pH was 7.9±0.25, NH3-N was 3.4±3.6 ppm, NO3-N was 949 
2.97±2.0 ppm, and NO2-N was 12.4±22.7 ppm. A 12 h light ⁄ 12 h dark photoperiod was 950 
maintained throughout the animal study period. 951 
  952 
Experimental diet 953 
The ground cassava chips sample was subjected to proximate analysis according to the 954 
Association of Official Analytical Chemists standard procedures (AOAC, 2007) with specific 955 
methods as follows: DM (135°C for 2 h, AOAC 930.15); Crude protein (CP) analysis (AOAC 956 
976.05) by determining nitrogen (N) using LECO TruSpec CN analyzer (LECO Corp., St. 957 
Joseph, MI, USA) and N multiplied by 6.25 to get the % CP; crude fiber (AOAC 978.10), crude 958 
fat (AOAC 920.39; using Soxhlet apparatus and petroleum ether), and ash (AOAC 942.05). Five 959 
isocaloric and isonitrogenous corn-soybean meal based diets were formulated (Table 3.1) to 960 
meet or exceed the nutritional requirements of tilapia fry (NRC, 1993). The diets varied in 961 
cassava chips in the amounts of 0% (control, T1), 4.38% (T2), 8.75% (T3), 17.50% (T4), and 962 
26.25% (T5) replacing 0, 12.5, 25, 50, and 75% of corn, respectively and were balanced with 963 
other ingredients. These treatments were allotted to tilapia in a completely randomized design.  964 
 All diets were analyzed following the same methods as the cassava chip samples (described 965 
above); the ingredient composition and analyzed nutritional values of all diets are presented in 966 
Table 3.1. 967 
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 968 
Intestinal microbiota sampling 969 
Tilapia intestinal microbiota was sampled monthly and the intestinal samples from two fish per 970 
tank were pooled (four samples per treatment). The fishes were euthanized with 0.6 g l-1 971 
Tricaine Methanesulfonate (TMS, Crescent Research Chemicals, Phoenix, AZ, USA), buffered 972 
with 0.12 g l-1 sodium bicarbonate in water originating from the corresponding rearing tank. 973 
Subsequently, fish were rinsed with 70% ethanol and sterile water before dissecting out 974 
aseptically the gut under a dissection microscope. Whole gut samples were flash frozen in liquid 975 
nitrogen and stored individually at 80oC until subsequent analyses. DNA extraction followed the 976 
protocol outlined by Yu and Morrison (2004) (Yu & Morrison, 2004). Microbial DNA was 977 
analyzed as outlined below. 978 
  979 
PCR-DGGE 980 
PCR amplification of the 16S rRNA V3 region was conducted with universal primers U2 and U3 981 
and a 40-60% DGGE analysis were conducted as described (Merrifield et al., 2010). 982 
Dendrograms were created from the DGGE results using ImageJ software.  983 
 984 
16S rRNA gene sequencing analysis 985 
Metagenomic analysis of the 16S rRNA V3 and V4 regions were conducted using the Illumina 986 
MiSeq system. The following primers were used prior to sequencing (in standard IUPAC 987 
nucleotide nomenclature): 16S Amplicon PCR Forward Primer = 988 
5'TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG 989 
16S Amplicon PCR Reverse Primer =  990 
5'GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC 991 
The quality of the reads was determined using FastQC and trimmed with Prinseq. QIIME was 992 
used for metagenomics quality control and taxon classification and quantification. DESeq2 was 993 
used for the differential abundance analysis of the operational taxonomic units (OTUs) 994 
identified. Krona charts (Ondov et al., 2011) were generated from the sequences using the MG-995 
RAST server (Glass & Meyer, 2011) to illustrate the composition of intestinal microbiomes of 996 






Statistical Analysis 1002 
Data were analyzed by ANOVA using Mixed procedure of SAS (SAS 9.2, SAS Institute Inc., 1003 
Cary, NC). Significant differences among treatments were assessed by Tukey’s test. A 1004 
significant level of P less than equal to 0.05 was used to declare difference. 1005 
 1006 
The metagenomic data were analyzed using DESeq2 analysis of deviance (ANODEV) and pair-1007 
wise comparisons between treatments. Significance was considered at P <0.05. For diversity 1008 
measures, Shannon Diversity Index was calculated for alpha diversity, and Bray-Curtis was 1009 
used to compare beta diversity along with a principal coordinates analysis. 1010 
  1011 
Results  1012 
The analyzed nutrient composition (as fed basis) of M. esculenta chips was as follows: Dry 1013 
Matter 90.06%, Ash , Crude Protein , Crude Fat , and Crude Fiber . Survival and growth 1014 
parameters of tilapia were not significantly different between treatments (data not presented). 1015 
Survival, growth rate, average daily feed intake, feed conversion ratio, protein efficiency ratio of 1016 
tilapia were not significantly different between treatments (data not presented). The mean 1017 
percent survival was 94-99% per treatment.  1018 
   1019 
Intestinal Microbiota from PCR-DGGE Results 1020 
Intestinal microbiota samples were different between groups, as shown in Figure 3.1. Clustering 1021 
in the dendrogram shows similarities between the control group and the 12.5% and 25% 1022 
cassava feed, while the 50% and 75% cassava feed clustered together. To better elucidate 1023 
these differences, a 16S rRNA gene sequencing analysis was performed on the samples. 1024 
  1025 
Intestinal Microbiota from Metagenomic Results 1026 
Table 3.2 provides a summary of the species counts and Shannon Diversity Index. The Control 1027 
group had the lowest index of diversity (1.315), while the 50% cassava group had the highest 1028 
(2.329). The highest species count was in the 75% cassava sample with 596 species identified, 1029 
while the Control had the lowest at 436.  1030 
 1031 
In Figure 3.2, the top 30 bacterial families are summarized per sample and the full Krona Charts 1032 
are shown in Figure 3.3. The four main Bacterial Phyla represented in all treatments included 1033 
Proteobacteria, Firmicutes, Planctomycetes, and Actinobacteria. The most common bacterial 1034 
 50 
families were the Gemmataceae and Streptococcaceae for all samples but the 50% cassava 1035 
sample which had Fusobacteriacea as the dominant family.   1036 
 1037 
The Principle Coordinate Analysis of the metagenomic results by Bacterial Families indicates 1038 
clustering of 75% and 12.5% Cassava and the 25% Cassava and Control (Figure 3.4).   1039 
 1040 
Discussion 1041 
Based on the results of this study, cassava chips can be incorporated to replace up to 75% of 1042 
the corn meal in tilapia diets without negative effects on growth or health of the fish. It has been 1043 
well documented that feed alters the intestinal microbiome within fishes, particularly by altering 1044 
the carbohydrate content of the diet (Haygood & Jha, 2018; D. Merrifield & Ringø, 2014; 1045 
Sukanta K Nayak, 2010; Ringø et al., 2010). According to the Shannon Diversity Index results, 1046 
with increasing cassava chip inclusion in the diet there was an increase in diversity up to 50% 1047 
corn replacement (17.5% total inclusion); therefore, cassava chip inclusion in the diet as a corn 1048 
replacement alters the intestinal microbiota of tilapia. 1049 
 1050 
The four main bacterial Phyla represented in all treatments included Proteobacteria, Firmicutes, 1051 
Planctomycetes, and Actinobacteria, which supports previous studies regarding the dominant 1052 
phyla in fish microbiomes based on metagenomic analyses (Tarnecki, Burgos, Ray, & Arias, 1053 
2017a). Within these phyla, the dominant bacterial families included Gemmataceae and 1054 
Streptococcaceae for all samples but the 50% cassava sample which had Fusobacteriacea as 1055 
the dominant family. To the authors’ knowledge, the only report of Gemmataceae in tilapia is 1056 
from Gaikwad, Shouche, and Gade (2017). There is very little known about the effects of this 1057 
bacterial family in the intestinal microbiome and more research should be conducted into its 1058 
potential importance.  1059 
 1060 
The Streptococcaceae family was significantly different between treatments (P<0.01) with the 1061 
highest count (22484 OTUs) in the control and lowest counts in the 50% Cassava (9272 OTUs) 1062 
and 75% Cassava (10458 OTUs) treatments, suggesting a decrease of Streptococcus species 1063 
with increased cassava chip inclusion in the diet. Streptococcus sp. are known pathogens of 1064 
freshwater species, including tilapia with Streptococcus agalactiae being one of the most well 1065 
studied (Amal & Zamri-Saad, 2011; Ng, Koh, Sudesh, & Siti-Zahrah, 2009).  1066 
 1067 
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Of the other bacterial families detected, Microbacteriaceae and Rhizobiaceae are soil microbes 1068 
that decompose organic material and may either be a product of remaining food particles in the 1069 
intestine or new decomposers in the tilapia intestinal tract and were found in higher abundance 1070 
in the cassava diets compared to the control.  Xanthobacteracea are chemoheterotrophic 1071 
bacteria that have not been previously reported in the intestinal tract of animals and decreased 1072 
in abundance with increasing cassava inclusion compared to the control. Finally, 1073 
Methylobacteriaceae were significantly different between the 75% Cassava treatment (6049 1074 
OTUs) and the Control (2566 OTUs) (P<0.01). This family has been described as a beneficial 1075 
species in the tilapia intestinal microbiome in previous studies, suggesting that the increase of 1076 
cassava in the diet may beneficially effect tilapia (Zheng et al., 2018).  1077 
 1078 
In conclusion, Manihot esculenta inclusion into the diets of tilapia did not negatively impact the 1079 
growth, but significantly altered the intestinal microbiome, suggesting that it may be used in 1080 
aquaculture. The increase of the Methylobacteriaceae family in the tilapia intestinal microbiota 1081 
suggest that cassava inclusion in the diet may beneficially affect tilapia. Additionally, the 1082 
reduction in levels in Streptococcaceae in the intestine of tilapia suggests that M. esculenta may 1083 
reduce pathogenic load in farmed tilapia.  Future studies should investigate the histological 1084 
effects of cassava in the diets of tilapia to better elucidate its potential as a prebiotic.   1085 
  1086 
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Table 3.1 Ingredient composition and nutrient content of diets fed in the cassava study 1087 
Ingredients  CSV0  CSV12.5  CSV25  CSV50  CSV75  
Corn  35 30.63 26.25 17.5 8.75 
SBM  35 35 35 35 35 
Cassava chips  0 4.38 8.75 17.5 26.25 
Profine1  11.54 11.54 13 13.04 14.04 
Soybean oil  7.5 7 6.04 4 2 
Molasses  5 5 5 6 6 
Others  5.96 6.46 5.96 6.96 7.96 
Total  100 100 100 100 100 
 
Calculated content, %  
DE, Kcal/kg  3450 3485 3514 3525 3550 
CP  26.94 26.73 27.45 27.13 27.35 
Ether extract  9.13 8.64 7.74 5.79 3.88 
Crude fiber  4.68 3.2 3.23 3.65 4.04 
ADF 4.47 3.85 3.95 4.2 4.59 
NDF 9.97 6.42 6.69 6.44 7.64 
Lysine  2.06 2.06 2.06 2.05 2.05 
Threonine  1.36 1.35 1.37 1.36 1.36 
Methionine  1 1 1.02 1.01 1.01 
Choline 
(mg/kg)  
1314 1293 1275 1254 1216 
Ca  0.153 0.171 0.173 0.217 0.254 
P  0.315 0.3125 0.297 0.29 0.284 
 1088 
1. Profine® Powdered Soy Protein Concentrate was purchased from the DuPont® Feed company, Wilmington, DE, USA 1089 
Ingredients are expressed as g per kg-1 diet. Dietary codes: CSV0 = Control, CSV12.5 = 12.5% 1090 
corn replacement, CSV25 = 25% corn replacement, CSV 50% = 50% corn replacement, CSV75 1091 
= 75% corn replacement. 1092 
 1093 
 1094 
  1095 
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Table 3.2 Number of reads, species counts, and Shannon Diversity Index values per sample. 1096 
 1097 
Sample Number of Reads Species Counts Shannon Diversity Index 
Control 99,931 436 1.315 
12.5% Cassava 115,882 511 1.566 
25% Cassava 88,329 536 1.361 
50% Cassava 102,742 543 2.329 
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Figure 3.1 Results of the PCR-DGGE analysis of cassava samples replacing 0%, 12.5%, 25%. 1102 





  1108 
 55 
Figure 3.2 Top 30 Family classification results per sample. Samples are labeled as follows: 1109 
Cass0 = Control; Cass12.5 = 12.5% Cassava; Cass25 = 25% Cassava; Cass50 = 50% 1110 

















Cass75 Cass50 Cass25 Cass12.5 Cass0
Gemmataceae Streptococcaceae Rhizobiaceae Rhodobacteraceae
Mycobacteriaceae Fusobacteriaceae Isosphaeraceae Methylobacteriaceae
Xanthobacteraceae Micrococcaceae Bacillaceae Lachnospiraceae
Methylocystaceae Parachlamydiaceae Enterobacteriaceae Microbacteriaceae
Bradyrhizobiaceae Bacteroidaceae Pseudonocardiaceae Enterococcaceae
Hyphomicrobiaceae Planctomycetaceae Ruminococcaceae Nocardioidaceae
Rhodospirillaceae Acidimicrobiaceae Oceanospirillaceae Veillonellaceae
Clostridiaceae
 56 
Figure 3.3 Krona charts of bacterial classifications by sample. 1117 
 1118 
 1119 
a) 75% Cassava     b) 50% Cassava 1120 
 1121 
   1122 




e) Control 1126 
 1127 
  1128 
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Figure 3.4 Principle Coordinate Analysis (PCoA) of the normalized relative abundance of all 1129 
samples based on family-level classifications. Samples are labeled as follows: Cass0-1 = 1130 
Control; Cass12-1 = 12.5% Cassava; Cass25-1 = 25% Cassava; Cass50-1 = 50% Cassava; 1131 
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CHAPTER 4 THE EFFECT OF MICROALGAE AS A FISHMEAL AND FISH OIL 1137 
REPLACEMENT ON THE INTESTINAL MICROBIOTA OF TILAPIA 1138 
 1139 
Abstract 1140 
The aquaculture industry has explored alternative protein and lipid sources for aquaculture feed 1141 
to reduce costs and promote sustainability. Microalgae is a desirable feed ingredient because it 1142 
is grown in high volume and can be selected for high levels of lipids and protein. Additionally, 1143 
microalgae have been recently explored as a prebiotic to promote the health of fish species 1144 
through the modulation of the intestinal microbiota. This study investigated the use of 1145 
microalgae as fishmeal and fish oil replacements and its effect on the intestinal histology and 1146 
microbiota of hybrid tilapia (O. niloticus x O. mossambicus). Feed intake and body weight was 1147 
recorded weekly and intestinal samples were collected monthly and processed for microbiota 1148 
analysis using metagenomics and histological analysis of the intestinal epithelia. Tilapia growth 1149 
performance was significantly higher in the 100% algae-based diet compared to the fishmeal 1150 
and fish oil control (P>0.05), suggesting that microalgae can completely replace fishmeal and 1151 
fish oil in the tilapia diets without negative impact. Microalgae inclusion into the tilapia diets did 1152 
not significantly alter the overall intestinal microbiota. However, several species were 1153 
significantly different between treatments, most notably an increase in Parabacteroides 1154 
goldsteinii in the 100% algal inclusion. P. goldsteinii is a known beneficial microbe in the human 1155 
GI tract, thus the inclusion of algae in the diets may be used as a strategy to modulate the gut 1156 
health of Tilapia. Additionally, several novel species were reported in tilapia including the two 1157 
most common species across all treatments, Mycobacterium pinnipedii, a closely related 1158 
species to the tuberculosis-causing Mycobacterium tuberculosis, and the non-tuberculosis 1159 
causing, Mycobacterium brasiliensis. Histological results did not show a significant difference 1160 
between treatments, suggesting that algae inclusion in the diet does not negatively affect the 1161 
health of tilapia. 1162 
 1163 




The largest costs in aquaculture production include the fish feed and maintenance of fish health 1168 
through disease prevention and treatment (El-Sayed & Tacon, 1997; FAO, 2016; Hardy, 2010; 1169 
Haygood & Jha, 2018; S. K. Nayak, 2010; Olsen & Hasan, 2012). Many fish feeds include 1170 
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protein content from wild caught fish, which has been shown to be unsustainable (El-Sayed & 1171 
Tacon, 1997; Naylor et al., 2009; New & Wijkström, 2002). Therefore, the aquaculture industry 1172 
has explored alternative protein and lipid sources for aquaculture feed. Since the European 1173 
Union 2006 ban on the use of antibiotics as a growth promoter in agriculture and aquaculture, 1174 
research has been directed into the use of prebiotics and probiotics to modulate the intestinal 1175 
microbiota of aquaculture species (Gifstad et al., 2010; Haygood & Jha, 2018; S. K. Nayak, 1176 
2010; Sukanta K Nayak, 2010). Prebiotics are compounds in food that induce the growth or 1177 
activity of beneficial microorganisms such as bacteria and fungi in the intestinal tract of the 1178 
species of interest. To date, the majority of prebiotic research has involved the use of non-1179 
digestible oligosaccharides and inulin (Llewellyn, Boutin, Hoseinifar, & Derome, 2014; Merrifield 1180 
& Ringø, 2014; Ringø et al., 2010).  1181 
 1182 
Modulation of the intestinal microbiota of aquaculture species through the use of prebiotics not 1183 
only benefits the health of the host, but also reduces costs to aquaculture production (Merrifield 1184 
& Ringø, 2014). Like prebiotics, feed ingredients with high fiber and resistant starch also 1185 
modulate the intestinal microbiota of the host while providing nutritional value for growth 1186 
performance. Microalgae have been considered as alternative feed ingredients to reduce the 1187 
reliance on wild-caught fishmeal and fish oil in the diets of aquaculture species up to 50-75% 1188 
replacement for corn/soymeal and fishmeal in the diet (Azaza et al., 2008; Benemann, 1992; 1189 
Hussein, Dabrowski, El-Saidy, & Lee, 2013; Lazo, Dinis, Holt, Faulk, & Arnold, 2000; Olvera-1190 
Novoa, Domínguez-Cen, Olivera-Castillo, & Martínez-Palacios, 1998; Schrader, Green, & 1191 
Perschbacher, 2011; Spolaore, Joannis-Cassan, Duran, & Isambert, 2006). They are ideal 1192 
alternative feed ingredients because they can be easily cultivated and can be selected for high 1193 
production of lipids and protein and may also modulate the intestinal microbiota of species of 1194 
interest. Arthrospira platensis is a nutritionally enriched filamentous cyanobacterium with known 1195 
anti-cancer and anti-oxidant properties in tilapia (Oreochromis niloticus) (Abdel-Tawwab & 1196 
Ahmad, 2009; B. Belal, 2012; Hassan et al., 2017; Ibrahem & Ibrahim, 2014; Mahmoud, El-1197 
Lamie, Kilany, & Dessouki, 2018). Schizochytrium limacinum is a Docosahexaeonic acid (DHA) 1198 
rich marine heterotroph that has successfully be used as a replacement for fish oil in red drum 1199 
(Sciaenops ocellatus) (Perez-Velazquez, Gatlin, González-Félix, & García-Ortega, 2018), 1200 
yellowtail (Seriola rivoliana) (Kissinger, García-Ortega, & Trushenski, 2016), and giant grouper 1201 
(Epinephelus lanceolotus) (García-Ortega, Kissinger, & Trushenski, 2016). The combination of 1202 
these two microbes was investigated as potential growth and health promoters in tilapia diets. 1203 
 1204 
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Tilapia (Oreochromis sp.) are the most widespread aquaculture species in the world due to their 1205 
relative fecundity, omnivorous feeding habits, and tolerance of marginal growing conditions, 1206 
making them ideal study species for alternative feed ingredients (FAO, 2016). Tilapia 1207 
(Oreochromis niloticus) is the second most farmed fish group worldwide and over the past 1208 
decade has quadrupled in production, largely due to their many characteristics conducive to 1209 
aquaculture conditions as well as to the high marketability and relatively stable market prices 1210 
(Ng and Romano, 2013). Production of tilapia in 2015 exceeded 5.7 million tons worldwide with 1211 
a value of over $9 billion USD and has continued to subsequently increase (FAO, 2016). With 1212 
an increasing demand for tilapia due to the increasing human population, producers must 1213 
continue to provide high-quality tilapia filets with minimal input costs to meet this demand. 1214 
 1215 
This study investigated the use of Arthrospira fusiformis and Schizochytrium limacinum as 1216 
fishmeal and fish oil replacements to reduce feed cost while promoting the intestinal health of 1217 
hybrid tilapia (O. niloticus x O. mossambicus) through the promotion of beneficial microbes. 1218 
 1219 
Materials and methods 1220 
All animal procedures were conducted in accordance with the approval (protocol #17-007) from 1221 
the Institutional Animal Care and Use Committee (IACUC) of the University of Hawaii, Honolulu, 1222 
HI, USA. 1223 
 1224 
Feeding trial 1225 
A feeding trial was conducted to study the replacement of fish meal, fish oil and soybean protein 1226 
concentrate by algal meals of Arthrospira platensis and Schizochytrium limacinum in diets for 1227 
tilapia. Five experimental diets were tested in fish with an initial weight of 0.9 ± 0.1 g. The 1228 
replacement levels were: 0, 25, 50, 75 and 100% (Table 4.1).  Each diet treatment was tested in 1229 
triplicate in a water recirculation system with tanks of 90 L volume each at a density of 15 fish 1230 
per tank. Fish were manually fed twice per day at 8 am and 2 pm for nine weeks. Fish feed 1231 
intake and fish mortality were recorded daily, and a photoperiod of 12L:12D was applied. Water 1232 
temperature, salinity and dissolved oxygen were measured in a daily basis in each tank with a 1233 
portable multi-meter (Pro 2030, YSI Inc., USA) and water pH and total ammonia nitrogen 1234 
measured weekly using a portable colorimeter (DR 900, Hach, USA). Water quality parameters 1235 
averages were maintained at: temperature: 28.3 ± 0.2°C, salinity 0.1 ± 0.0 ppt, dissolved 1236 
oxygen 6.5 ± 0.1 mg/L, pH 6.7 ± 0.3 and total ammonia nitrogen 0.0 ± 0.0 mg/L. 1237 
 1238 
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Intestinal microbiota sampling 1239 
Tilapia intestinal microbiota was sampled monthly and the intestinal samples from two fish per 1240 
tank were pooled (three samples per treatment). The fishes were euthanized with 0.6 g l-1 1241 
Tricaine Methanesulfonate (TMS, Crescent Research Chemicals, Phoenix, AZ, USA), buffered 1242 
with 0.12 g l-1 sodium bicarbonate in water originating from the corresponding rearing tank. 1243 
Subsequently, fish were rinsed with 70% ethanol before dissecting out aseptically the gut under 1244 
a dissection microscope. Whole gut samples were flash frozen in liquid nitrogen and stored 1245 
individually at -80oC until subsequent analyses. DNA extraction followed the protocol outlined by 1246 
Yu and Morrison (2004) (Yu & Morrison, 2004). Microbial DNA was analyzed as outlined below. 1247 
  1248 
16S rRNA gene sequencing analysis 1249 
Metagenomic analysis of the 16S rRNA V3 and V4 regions were conducted using the Illumina 1250 
MiSeq system. The following primers were used prior to sequencing (in standard IUPAC 1251 
nucleotide nomenclature): 16S Amplicon PCR Forward Primer = 1252 
5'TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG 1253 
16S Amplicon PCR Reverse Primer =  1254 
5'GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC 1255 
The quality of the reads was determined using FastQC and trimmed with Prinseq. QIIME was 1256 
used for metagenomics quality control and taxon classification and quantification. DESeq2 was 1257 
used for the differential abundance analysis of the operational taxonomic units (OTUs) 1258 
identified. Krona charts (Ondov, Bergman, & Phillippy, 2011) were generated from the 1259 
sequences using the MG-RAST server (Glass & Meyer, 2011) to illustrate the composition of 1260 
intestinal microbiomes of tilapia fed different inclusion levels of moringa. 1261 
 1262 
Histological Sampling of Intestines 1263 
Initial histological samples included 10 fish species after acclimation. At the end of the trial, two 1264 
fish per tank were sampled for histological appraisal of the distal intestines. The following 1265 
methods are from Rodiles et al. (2015). For light microscopy, the tissue samples were fixed in 1266 
10% formalin and transferred to 70% ethanol after 24h. Samples were dehydrated in graded 1267 
ethanol concentrations prior to embedding in paraffin wax. In each specimen, multiple sections 1268 
(5 μm) were stained with haematoxylin and eosin (H & E) and Alcian Blue-PAS to assess the 1269 
mucosal fold length, intestinal perimeter ratio (arbitrary units; AU), intraepithelial leucocyte 1270 
(IELs) levels and goblet cell abundance in the epithelium. IELs and goblet cells will be counted 1271 
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across a standardized distance of 100 μm and then calculated by averaging the cell numbers 1272 
from all samples within each treatment.  1273 
 1274 
Statistical Analysis 1275 
The microbiota data were analyzed using DESeq2 analysis of deviance (ANODEV) and pair-1276 
wise comparisons between treatments. Significance was considered at P <0.05. For diversity 1277 
measures, Shannon Diversity Index was calculated for alpha diversity, and Bray-Curtis was 1278 
used to compare beta diversity along with a principal coordinates analysis. 1279 
 1280 
The histological parameters were analyzed by ANOVA using Mixed procedure of SAS (SAS 9.2, 1281 
SAS Institute Inc., Cary, NC). Significant differences among treatments were assessed by 1282 
Tukey’s test. A significant level of P less than equal to 0.05 was used to declare difference. 1283 
 1284 
Results  1285 
Intestinal Microbiota Metagenomic Results 1286 
Table 4.2 provides a summary of the species counts and Shannon Diversity Index. The Control 1287 
group had the lowest index of diversity (2.248), while the 25% algae group had the highest 1288 
(2.499) followed closely by the 100% algae group (2.453). The highest species count was in the 1289 
50% algae group with 916 species identified, while the 75% algae group had the lowest at 850. 1290 
There were no significant differences between the beta diversity in each group, which is 1291 
apparent in Figures 4.2 and 4.3.   1292 
 1293 
In Figure 4.1, the top 30 bacterial families are summarized per sample and the full Krona Charts 1294 
are shown in Figure 4.2. The four main Bacterial Phyla represented in all treatments included 1295 
Actinobacteria, Proteobacteria, Firmicutes, and Fusobacteria. The most common bacterial 1296 
families were the Mycobacterium, Streptomyces, and Singulisphaera for all samples but the 1297 
25% microalgae which had Cetobacterium as the second most dominant family and Nocardia as 1298 
the third most dominant family behind Mycobacterium. Upon further investigation, the 1299 
Mycobacterium Family was dominated by two species, Mycobacterium pinnipedii, a closely 1300 
related species to the tuberculosis-causing Mycobacterium tuberculosis, and the non-1301 
tuberculosis causing, Mycobacterium brasiliensis.   1302 
 1303 
The Principle Coordinate Analysis of the metagenomic results by Bacterial Families indicates 1304 
clustering of the Control, 75%, and 100% Algae with the 25% and 50% as outliers (Figure 4.3).   1305 
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 1306 
Intestinal Histology Results 1307 
The intestinal histology results showed a significant difference in villi height between groups, 1308 
including the initial sample (p < 0.001) and between treatments at the end of the trial 1309 
(p=0.0018). The ALG25 treatment (150.77 µm ± 33.65) had significantly smaller villi than the 1310 
initial samples (238.81µm ± 33.17). The ALG25 treatment (150.77 µm ± 33.65) also had 1311 
significantly smaller villi than the ALG0 samples (247.29µm ± 89.76). There was no significant 1312 
difference (p > 0.05) between goblet cell counts and intraepithelial leucocyte (IEL) levels 1313 
between treatments. There were increased IEL levels in the ALG50 and ALG75 treatments; 1314 
however, it was not significantly different from the control. Additionally, there were increased 1315 
goblet cells in the ALG50 treatment, suggesting minor inflammation in the tissues.  1316 
 1317 
Discussion 1318 
To date, few intestinal microbiota studies have been conducted on organisms fed microalgae, 1319 
including; gilthead seabream (Sparus aurata) fed two types of algae (Tetraselmis chuii and 1320 
Phaeodactylum tricornutum) and the probiotic Bacillus subtilis (Esteban et al., 2012); rainbow 1321 
trout (Oncorhynchus mykiss) fed Schizochytrium limacinum (Lyons, Turnbull, Dawson, & 1322 
Crumlish, 2017), and another study involved feeding mice one of three different algal treatments 1323 
(Nostoc commune, Spirulina platensis, or Afanizominon flos-aquae) (Rasmussen, Martínez, 1324 
Lee, & Walter, 2009). The study by Cerezuela, et al. (2012) found significant reduction in the 1325 
microbial diversity and total numbers with increasing levels of algal inclusion in the diet; 1326 
whereas, Lyons, et al. (2017) and Rasmussen, et al. (2009) did not find significant differences in 1327 
total microbial counts, but Rasmussen, et al. (2009) did find significant differences between the 1328 
microbial community in the control vs. experimental group fed N. commune. 1329 
 1330 
Based on the results of this study, microalgae can be incorporated to replace up to 100% of the 1331 
fishmeal and fish oil in tilapia diets without negative effects on growth or health of the fish. It has 1332 
been well documented that feed alters the intestinal microbiome within fishes, particularly by 1333 
altering the carbohydrate content of the diet (Haygood & Jha, 2018; Merrifield & Ringø, 2014; 1334 
Sukanta K Nayak, 2010; Ringø et al., 2010). According to the Shannon Diversity Index results, 1335 
with increasing microalgae inclusion in the diet there was an increase in diversity with the 1336 
exception of the 75% microalgae group; therefore, microalgae inclusion in the diet as a fishmeal 1337 
and fish oil replacement alters the intestinal microbiota of tilapia. 1338 
 1339 
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The four main bacterial Phyla represented in all treatments included Actinobacteria, 1340 
Proteobacteria, Firmicutes, and Fusobacteria, which supports previous studies regarding the 1341 
dominant phyla in fish microbiomes based on metagenomic analyses (Tarnecki, Burgos, Ray, & 1342 
Arias, 2017). The most common bacterial families were the Mycobacterium, Streptomyces, and 1343 
Singulisphaera for all samples but the 25% microalgae which had Cetobacterium as the second 1344 
most dominant family and Nocardia as the third most dominant family behind Mycobacterium. 1345 
Cetobacterium have been reported in tilapia intestinal microbiota previously (Larsen, 1346 
Mohammed, & Arias, 2014; Pedrotti et al., 2015); however, their role in the intestine is unclear.  1347 
 1348 
The Mycobacterium Family was dominated by two species, Mycobacterium pinnipedii, a closely 1349 
related species to the tuberculosis-causing Mycobacterium tuberculosis, and the non-1350 
tuberculosis causing, Mycobacterium brasiliensis. To the author’s knowledge, this is the first 1351 
case of these species reported in tilapia. While Mycobacterium pinnipedii is a pathogen of seals, 1352 
these species were found in abundance across all diet types and did not seem to have 1353 
deleterious effects on growth parameters, survival, and health parameters measured in this 1354 
study.  1355 
 1356 
The family Bacillaceae was significantly different between treatments (p < 0.05) with the highest 1357 
levels in the ALG 100 (2062 OTUs) and ALG 50 (1757 OTUs). Bacillaceae includes several 1358 
probiotic species tested on tilapia, including: Bacillus subtilis (Adeoye et al., 2016; Efendi & 1359 
Yusra, 2014; Essa, El-Serafy, & El-Ezabi, 2010; He, Zhang, Xu, Yalin, et al., 2013; He, Zhang, 1360 
Xu, Yang, et al., 2013; Iwashita, Nakandakare, Terhune, Wood, & Ranzani-Paiva, 2015; Kathia, 1361 
Cienfuegos Martinez, del Carmen, Monroy Dosta Maria, Aida, Hamdan Partida, Jorge, Castro 1362 
Mejia, Feliz, Aguirre Garrido Jose, Amadeo, 2018; Ng, Kim, Romano, Koh, & Yang, 2014; 1363 
Rahman et al., 2009; Rodiles et al., 2015; Rurangwa et al., 2009; Soltan & El-Laithy, 2008; 1364 
Standen et al., 2015; Telli et al., 2014; Zhou, Tian, Wang, & Li, 2010); Bacillus pumilus (Adeoye 1365 
et al., 2016; Aly, Mohamed, & John, 2008); and Bacillus licheniformis (Adeoye et al., 2016; Ng 1366 
et al., 2014). These three Bacillus species are confirmed probiotics of tilapia species and their 1367 
benefits include improving both growth and health parameters. With increasing levels of 1368 
Arthrospira fusiformis and Schizochytrium limacinum in the diets of tilapia, the Bacillaceae 1369 
family has increased which may promote the health and growth of tilapia without having to 1370 
include these microbes as separate probiotic ingredients.   1371 
 1372 
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While the intestinal morphology of the tilapia was significantly different between the ALG25 1373 
treatment and the control, there is no significant difference in the increased algal inclusion levels 1374 
up to 100% replacement of fishmeal and fish oil. There was no significant difference in the 1375 
goblet cell and intraepithelial leucocyte levels between all treatments. 1376 
 1377 
In conclusion, Arthrospira fusiformis and Schizochytrium limacinum inclusion into the diets of 1378 
tilapia significantly increased the Bacteriaceae family in the tilapia intestinal microbiota, 1379 
suggesting that microalgae inclusion in the diet may beneficially affect tilapia. More research 1380 
into other histological parameters will help to determine if Arthrospira fusiformis and 1381 
Schizochytrium limacinum have beneficial effects on the health of tilapia.  1382 
 1383 
  1384 
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Table 4.1 Ingredient composition and nutrient content of diets fed in the microalgae study 1385 
 1386 
 Diets (g/kg) 
Ingredient ALG-0 ALG-25 ALG-50 ALG-75 ALG-100 
Fish meal 400 300 200 100 0 
Fish oil 76.06 57.05 38.03 19.02 0 
Arthorspira 0 165.47 330.99 496.42 661.9 
Schizochytrium 0 40.48 80.98 121.47 161.97 
Soy Protein Concentrate 195.58 146.69 97.75 48.9 0 
Dextrin 262.37 223.31 184.24 145.18 106.12 
Alginate 20 15 10 5 0 
Di-calcium phosphate 10 10 10 10 10 
Vitamin premix 20 20 20 20 20 
Mineral premix 10 10 10 10 10 
Lysine 0 3 6 9 12 
Methionine 0 2 4 6 8 
Taurine 6 7 8 9 10 
      
Total 1000.0 1000.0 1000.0 1000.0 1000.0 
 1387 
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Table 4.2 Number of reads, species counts, and Shannon Diversity Index values per sample. 1390 
 1391 
Sample Total Reads Species Count Shannon Diversity Index 
Control 102,963 871 2.248 
25% Algae 118,261 901 2.499 
50% Algae 116,228 916 2.405 
75% Algae 106,699 850 2.274 
100% Algae 96,283 874 2.453 
 1392 
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Figure 4.1 Top 30 Genus classification results per sample. Samples are labeled as follows: 1395 
ALG0 = control, ALG25 = 25% algae, ALG50 = 50% algae, ALG75 = 75% algae, ALG100 = 1396 
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Figure 4.2 Krona charts of bacterial classifications by sample. 1402 
 1403 
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Figure 4.3 Principle Coordinate Analysis (PCoA) of the normalized relative abundance of all 1408 
samples based on family-level classifications. Samples are labeled as follows: ALG0-2 = 1409 
control, ALG25-2 = 25% algae, ALG50-2 = 50% algae, ALG75-2 = 75% algae, ALG100-2 = 1410 
100% algae. 1411 
 1412 
 1413 
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CHAPTER 5 DISCUSSION 1415 
 1416 
The intestinal microbiome is a dynamic ecosystem that is highly regulated by the host (de Blas 1417 
et al., 2010). Changes in endocrine signaling pathways are driven by the enteric nervous 1418 
system and allow fish to adapt their gastrointestinal (GI) characteristics, including the 1419 
composition of the microbiome (de Blas et al., 2010; D. Merrifield & Ringø, 2014). While 1420 
fermentation is important in other vertebrates, particularly humans and ruminants, it is not well 1421 
understood in fish. Many species of bacteria are present in the gastrointestinal tract and are 1422 
known to break down non-digestible carbohydrates producing metabolites that are important to 1423 
the host, such as short-chain fatty acids. Therefore, it is assumed that these bacteria play a 1424 
similar role in fish digestion as they do in mammalian digestion (Gibson & Roberfroid, 1995; D. 1425 
Merrifield & Ringø, 2014).  1426 
 1427 
The composition of the gastrointestinal microbiota is highly dependent on host species-specific 1428 
parameters including; anatomy, endogenous inputs of digestive secretions, pH, osmolality, 1429 
redox potential, compartment size and structure, and passage rates and residence times (D. 1430 
Merrifield & Ringø, 2014). The anatomy of the GI tract varies widely between species and is 1431 
primarily dependent on the environment and feeding habits. Tilapia (Oreochromis spp.) are 1432 
primarily freshwater omnivores with a digestive tract composed of a mouth, esophagus, 1433 
stomach, midgut, and hindgut. The intestinal tract (midgut and hindgut) are divided into the 1434 
following sections hepatic loop, proximal major coil, gastric loop, distal major coil, and terminal 1435 
segment (Smith, Smith, Tengjaroenkul, & Lawrence, 2000). Each segment contains 1436 
autochthonous (resident) and allochthonous (transient) microbial communities that affect the 1437 
health and survival of the host (D. Merrifield & Ringø, 2014).  1438 
 1439 
The GI microbiome of fish is initially colonized at hatching and can change throughout the life 1440 
cycle of the fish, particularly as their feeding preferences change (Giatsis et al., 2014; Pérez et 1441 
al., 2010). Herbivorous fish contain the most diverse microbiome, as seen in other vertebrate 1442 
species. For tilapia, their intestinal microbiome is highly diverse due to their omnivorous nature 1443 
with a preference for feeding on plant and algal material. The Proteobacteria and Firmicutes 1444 
Phyla tend to dominate the fish GI microbiome (Haygood & Jha, 2018; Mansfield et al., 2010; 1445 
Zheng et al., 2018). The “normal” microbiome of fish species are autochthonous species that 1446 
cause no damage to, and possibly even benefit, their host. Known benefits of microbiota include 1447 
their ability to regulate digestion and energy homeostasis, prevent colonization of infectious 1448 
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agents, help maintain the mucosal immunity of their host, promote angiogenesis, and are known 1449 
to regulate 212 genes in zebrafish (Cahill, 1990; Merrifield & Ringø, 2014; Nayak, 2010; 1450 
Nicholson et al., 2012).  1451 
 1452 
In addition to the host-specific parameters listed previously, the intestinal microbiome of fish is 1453 
dependent on environmental factors and the diet of the fish. Environmental factors are known to 1454 
affect the growth and development of the intestinal microbiome, including seasonal changes in 1455 
temperature, daily fluctuations in salinity, and alterations to the environment. These factors may 1456 
highly influence the colonization of the intestinal microbiome and help determine the mature 1457 
microbiome of the adult fish (Giatsis et al., 2014; D. Merrifield & Ringø, 2014; Pérez et al., 1458 
2010).  1459 
 1460 
The two most highly investigated areas for modulation of the intestinal microbiota are probiotics 1461 
and prebiotics in diet inclusion (Haygood & Jha, 2018; D. Merrifield & Ringø, 2014). Probiotics 1462 
include live microorganisms that have different beneficial characteristics to their host (Nayak, 1463 
2010; Tuan, Duc, & Hatai, 2013). The vast majority of probiotics studied to date are Lactic Acid 1464 
Bacteria, but the other main probiotics in aquatic animals include: Aeromonas, Alteromonas, 1465 
Enterobacter, Flavobacterium, Pseudomonas, Pseudoalteromonas, Phaecobacter, 1466 
Roseobacter, Shewanella, Vibrio, Arthrobacter, Bacillus, Clostridium, Micrococcus, 1467 
Debaryomyces, and Saccharomyces species (D. Merrifield & Ringø, 2014). Probiotics have 1468 
been shown to enhance survival, development, nutrition, and disease resistance in the host 1469 
species.  1470 
 1471 
Prebiotics are non-digestible food ingredients that beneficially affect the host by selectively 1472 
stimulating the growth and/or activity of one or a limited number of bacterial species already 1473 
residing in the colon, and thus attempt to improve host health (Gibson & Roberfroid, 1995). Due 1474 
to the possible environmental issues with probiotics, many companies have investigated the use 1475 
of prebiotics to promote the growth of beneficial autochthonous bacterial species present in the 1476 
fish. The most common prebiotics used are inulin, various oligosaccharides, GroBiotic®, and 1477 
Previda™. Prebiotics are required by bacteria that produce short-chain organic acids that have 1478 
beneficial effects on the host. By incorporating prebiotics into the feed, the GI microbiota can be 1479 
modulated to promote beneficial species, in turn providing the following benefits to the host: 1480 
modulation of blood lipid levels; GI/systemic immunomodulation; energy for intestinal 1481 
proliferation; improved intestinal barrier function; reduced pH which aids in mineral absorption 1482 
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and general nutritional support; and enhancing pathogen resistance, reducing toxic microbial 1483 
metabolites, and suppressing intestinal inflammation (D. Merrifield & Ringø, 2014). 1484 
  1485 
The GI microbiome of tilapia is highly varied depending on species and location. Currently, very 1486 
little is known of the “normal” tilapia microbiota present in the gastrointestinal tract. Early 1487 
investigations of the intestinal microbiota of tilapia species utilized culture-dependent techniques 1488 
and were limited to identification of the most common and easily cultured species present. As 1489 
reviewed by Cahill (1990), the bacteria present in the intestinal tract of tilapia included 1490 
Pseudomonas sp., Virbio sp., Aeromonas sp., Enterobacteriaceae sp., and other unidentified 1491 
species. A study by Molinari et al. (2003) examined the microflora in mature tilapia cultured in a 1492 
semi-intensive system. They found the following bacteria present: Aeromonas hydrophila, A. 1493 
veronii, Burkholderia cepacia, Chromobacterium violaceum, Citrobacter freundii, Escherichia 1494 
coli, Flavimonas oryzihabitans and Plesiomonas shigelloides. Another study by Pakingking, 1495 
Palma, & Usero (2015) cultured microbial species present in mature tilapia grown in earthen 1496 
ponds. They identified the following heterotrophic aerobic bacteria in the tilapia intestinal tract: 1497 
Aeromonas hydrophila, A. sobria, Bacillus sp., Citrobacter koseri, Edwardsiella tarda, 1498 
Edwardisella hoshinae, Enterobacter cloacae, Klebsiella oxytoca, Pasteurella pneumotropica, 1499 
Photobacterium damselae, Plesiomonas shigelloides, Pseudomonas aeruginosa, Pseudomonas 1500 
fluorescens, Pseudomonas luteola, Pseudomonas putida, Shewanella putrefaciens, 1501 
Staphyloccocus sp., Vibrio cholera, V. fluvialis, V. vulnificus, and unidentified gram-negative rod 1502 
species.  1503 
 1504 
Recent advances in the identification of microbiota using molecular techniques have expanded 1505 
our knowledge of fish microbiota ten-fold, with particular attention given to salmonids (Merrifield 1506 
& Ringø, 2014; Nayak, 2010). Though many molecular studies summarized below investigate 1507 
the modulation of intestinal microbiota of tilapia, to the authors’ knowledge, the first attempt to 1508 
characterize the core microbiota of wild cichlid’s GI tract was only recently completed by Baldo, 1509 
Riera, Tooming-Klunderud, Albà, & Salzburger (2015). Using 16S rRNA pyrosequencing of 1510 
microbial DNA samples from ten cichlid species, they determined the core bacterial taxa present 1511 
in at least 80% of the individuals.  The species identified represent a diverse group of phyla 1512 
including Actinobacteria, Bacteroidetes, Firmicutes, Fusobacteria, Planctomcetes, and 1513 
Verrucomicrobia. The representative taxon from these phyla included: Cetobacterium somerae, 1514 
Clostridium perfringens, Plesiomonas shigelloides, Turicibacter sp., Clostridium XI sp., 1515 
Aeromonas sp., Neisseriacea, Lachnospiraceae, Clostridiales, Clostridiaceae, Gemmataceae, 1516 
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Acromobacter sp., Bacillus sp., and Pirellulaceae (Baldo et al., 2015). This study can be used 1517 
as a baseline for intestinal modulation of microbiota in aquaculture.  1518 
 1519 
Yeast such as Saccharomyces cerevisiae are important heterotrophic fermenters in the GI tract 1520 
and have been proposed as a probiotic for tilapia (Abdel-Tawwab et al., 2008; Ayyat et al., 1521 
2014; He et al., 2009; Lara-Flores et al., 2003; D. Merrifield & Ringø, 2014). Several yeast 1522 
species, including Kloeckera apiculata, Cadida sp., Metcschnikowia sp., and Rhodotorula sp., 1523 
have been described in finfish other than tilapia (Gatesoupe, 2007; D. Merrifield & Ringø, 2014). 1524 
Yeasts are known immuno-stimulants in fish and may promote growth and development in older 1525 
fish (Gatesoupe, 2007). However, despite understanding the importance of yeast in the GI tract 1526 
of fishes, no studies have investigated the naturally occurring presence or function of eukaryotic 1527 
autochthonous intestinal microbiota in tilapia.  1528 
 1529 
The purpose of this research was to determine the effects of alternative feed ingredients on the 1530 
GI microbiota of hybrid tilapia (Oreochromis niloticus x. O. mossambicus). The alternative feed 1531 
ingredients investigated in these studies were moringa (Moringa stenopetala), cassava (Manicot 1532 
esculenta), and microalgae (Arthrospira fusiformis and Schizochytrium limacinum) to replace 1533 
fishmeal, corn, and fishmeal/fish oil respectively. Moringa can be incorporated up to 12%, 1534 
cassava up to 26.25%, and microalgae up to 83.4% of the diet of hybrid tilapia without 1535 
negatively affecting the growth and production of the fish. By incorporating these alternative 1536 
feed ingredients on a large scale, producers can reduce overall costs without incurring negative 1537 
effects on production of hybrid tilapia. 1538 
 1539 
The overall intestinal microbiota were significantly altered with moringa and cassava inclusion in 1540 
the diets. Previous research stated that Proteobacteria, Firmicutes, Planctomycetes, and 1541 
Actinobacteria were the vast majority of bacteria present in the tilapia samples (Rodiles et al., 1542 
2015; Tarnecki, Burgos, Ray, & Arias, 2017b) and this work was supported in our research. The 1543 
microalgae also had a large representation from Fusobacteria in the metagenomic results. 1544 
While the same phyla were represented across trials, the bacterial families were varied. The top 1545 
ten families for each trial are presented in Table 5.1. The families represented predominantly 1546 
across all treatments were: Microbacteriaceae, Rhodobacteraceae, Mycobacteriaceae, 1547 
Isosphaeraceae, Xanthobacteraceae, and Microbacteriaceae.   1548 
 1549 
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With moringa inclusion, the Oxalobacteraceae and Comamonadaceae families were 1550 
significantly higher and the Proteobacteraceae family was significantly reduced, suggesting 1551 
there may be anti-inflammatory effects of Moringa stenopetala similar to the known effects of 1552 
Moringa oleifera. With cassava inclusion, Microbacteriaceae, Rhizobiaceae, and 1553 
Methylobacteriaceae were significantly higher, and Streptococcaceae and Xanthobacteracea 1554 
were significantly reduced. The increase of the Methylobacteriaceae family in the tilapia 1555 
intestinal microbiota suggest that cassava inclusion in the diet may beneficially affect tilapia. 1556 
Additionally, the reduction in levels in Streptococcaceae in the intestine of tilapia suggests that 1557 
M. esculenta may reduce pathogenic load in farmed tilapia. Finally, microalgae inclusion 1558 
increased the levels of Bacillaceae, a known probiotic family which suggests that microalgae 1559 
inclusion in the diet may beneficially affect tilapia. The most concerning find in this study was 1560 
the presence of Mycobacterium pinnipedii, a closely related species to the tuberculosis-causing 1561 
Mycobacterium tuberculosis across all microalgae treatments and the control. To the author’s 1562 
knowledge, this is the first case of these species reported in tilapia. While Mycobacterium 1563 
pinnipedii is a pathogen of seals, these species were found in abundance across all diet types 1564 
and did not seem to have deleterious effects on growth parameters, survival, and health 1565 
parameters measured in this study.  1566 
 1567 
The results of these studies provide some of the first research into the effects of these alterative 1568 
feed ingredients on the intestinal microbiota of hybrid tilapia. While it is well documented that 1569 
food ingredients alter the intestinal microbiota of humans (Foxx-Orenstein & Chey, 2012; 1570 
Gerritsen, Smidt, Rijkers, & De Vos, 2011; Gibson & Roberfroid, 1995; Hooper et al., 2002), 1571 
more work is required to study the effects of feed ingredients on the intestinal microbiota and 1572 
overall health of tilapia.   1573 
 1574 
Future Research 1575 
Based on the results of these studies, the following are suggestions for future research: 1576 
investigation of other alternative feed ingredients to promote growth, health, and modulation of 1577 
the intestinal microbiome of tilapia; investigations into the mode of action for colonization and 1578 
maturation of the intestinal microbiome; and investigations into the mode of action for the 1579 
intestinal microbiome effects on health and growth of fish, particularly tilapia. According to 1580 
Lescak & Milligan-Myhre (2017), teleost species, like tilapia, are ideal model organisms to study 1581 
the evolution and interactions between the host and their microbiome. They state “the extensive 1582 
variation in the physiology, ecology, and natural history of fish enriches studies of the evolution 1583 
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and ecology of host-microbe interactions. They share physiological and immunological features 1584 
common among vertebrates, including humans, and harbor complex gut microbiota, which 1585 
allows identification of the mechanisms driving microbial community assembly. Their 1586 
accelerated life cycles and large clutch sizes and the ease of sampling both internal and 1587 
external microbial communities make them particularly well suited for robust statistical studies of 1588 
microbial diversity. Gnotobiotic techniques, genetic manipulation of the microbiota and host, and 1589 
transparent juveniles enable novel insights into mechanisms underlying development of the 1590 
digestive tract and disease states. Many diseases involve a complex combination of genes 1591 
which are difficult to manipulate in homogeneous model organisms. By taking advantage of the 1592 
natural genetic variation found in wild fish populations, as well as of the availability of powerful 1593 
genetic tools, future studies should be able to identify conserved genes and pathways that 1594 
contribute to human genetic diseases characterized by dysbiosis.”  1595 
 1596 
While probiotics have been extensively studied in tilapia, two of the main challenges of the use 1597 
of probiotics in aquaculture are the costs and shelf-life of the probiotic treatments. Since the 1598 
bacterial species of interest must be alive at the time of consumption, they are difficult to 1599 
transport across long distances and may lose effectiveness if not stored at ideal temperatures 1600 
(D. Merrifield & Ringø, 2014). Prebiotics are an effective alternative at promoting beneficial 1601 
microbes in the host; however, they are an additional cost to the farmer. By using alternative 1602 
feed ingredients as prebiotics, the costs of the aquaculture feed can be reduced while the 1603 
effects of the promotion of beneficial bacterial species can be maintained. Therefore, research 1604 
into the use of commercially available alternative feed ingredients should be continued. The 1605 
research should focus particularly on the growth, health, and economic effects of the proposed 1606 
feed ingredients. 1607 
 1608 
While many species have been labeled as “probiotic” and “beneficial microbes,” there is still a 1609 
lack of knowledge into the mode of action of these species on the host. The colonization and 1610 
maturation of the intestinal microbial ecosystem is dependent on the rearing conditions (Dehler, 1611 
Secombes, & Martin, 2017; Waché et al., 2006), genetics of the host (Lescak & Milligan-Myhre, 1612 
2017), and feed ingredients, including probiotics and prebiotics (Dimitroglou et al., 2011; 1613 
Haygood & Jha, 2018; D. Merrifield & Ringø, 2014; Ringø et al., 2010). Because this dynamic 1614 
environment is difficult to replicate in laboratory conditions, very little is known of the 1615 
colonization and maturation of intestinal microbes.  1616 
 1617 
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Finally, as stated previously, the known benefits of microbiota include their ability to regulate 1618 
digestion and energy homeostasis, prevent colonization of infectious agents, help maintain the 1619 
mucosal immunity of their host, promote angiogenesis, and are known to regulate 212 genes in 1620 
zebrafish (Cahill, 1990; Merrifield & Ringø, 2014; Nayak, 2010; Nicholson et al., 2012). While 1621 
the effects of probiotics are recorded in the host, little is known of the exact modes of action of 1622 
these microbes. Gene expression studies can be used to determine what host genes are 1623 
affected by the application of species of interest and classify bacterial species into different 1624 
groups based on their beneficial effects. Additionally, if the host intestinal environment could be 1625 
replicated in vitro, more work can be done on determine the modes of action and identification 1626 
of new beneficial species.   1627 
 1628 
The overall goal is to reduce the production costs of farmers to promote the production of high-1629 
quality fish protein for an ever-increasing human population. Once the effects of intestinal 1630 
microbes are better understood, they can be modulated to increase the growth and health 1631 
benefits to the aquaculture species of interest to meet this goal. 1632 
  1633 
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Table 5.1 Summary of the top ten bacterial families found in each study; moringa, cassava, and 1634 
microalgae. Each family and average OTUs are listed. 1635 
 1636 
Moringa Cassava Microalgae 
Family OTUs Family OTUs Family OTUs 
Microbacteriaceae 5749 Gemmataceae 20832.2 Mycobacteriaceae 25379 
Sphingomonadaceae 1809 Streptococcaceae 14352.4 Streptomycetaceae 4252 
Chitinophagaceae 1797 Rhizobiaceae 4720.6 Isosphaeraceae 4197 
Cytophagaceae 1658 Rhodobacteraceae 3935.8 Xanthobacteraceae 4085 
Rhodospirillaceae 1504 Mycobacteriaceae 3901.4 Microbacteriaceae 3541 
Caulobacteraceae 1348 Fusobacteriaceae 3892.4 Paenibacillaceae 2974 
Saprospiraceae 1159 Isosphaeraceae 3633.6 Rhodobacteraceae 2401 
Sphingobacteriales 1126 Methylobacteriaceae 3542.6 Clostridiaceae 2223 
Bacteroidetes Family 1096 Xanthobacteraceae 3253 Pseudonocardiaceae 2080 
Rhodobacteraceae 864 Micrococcaceae 1743.4 Nocardiodiaceae 1852 
 1637 
 1638 
  1639 
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